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ABSTRACT 
 
Bryant Tai Wu; Industrially Scalable Liver Organoids 
(Under the direction of Lola M. Reid) 
 
Tissue engineering research is a multidisciplinary effort that incorporates the use of 
resources from various fields to address specific problems. Biomatrix scaffolds have recently 
been more widely used to improve the culture of cells by supporting their differentiated functions 
more than any known matrix extract or purified matrix component. However, they are not readily 
converted to industrial scale usage. Additionally, improved imaging techniques using ultrasound 
have been developed and are being used to characterize the biomatrix scaffolds in more detail 
to assess which preparation might be best for industrially scaled studies. The primary objective 
of this thesis was to identify methods that would most optimally use the biomatrix scaffold 
extracts while preserving the critical components of the matrix but in a way that was scalable for 
use in industry. We also demonstrate the use of novel ultrasound technologies that are non-
invasive and non-destructive in the evaluation of biomatrix scaffolds.
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CHAPTER I 
 
Background 
 
Need for Ex Vivo Human Cell Cultures as Models for Experimental Studies 
Various limitations exist in the use of human and animal models in research ranging 
from a lack in availability of test subjects to the practicality of experimental protocols to handle 
large amounts of samples and even to ethical issues concerning the test subjects during 
experimentation. Additionally, the correlation between animal models and humans is often not 
sufficient to accurately model the clinical efficacy of certain treatments. Human tissues are 
obviously the ideal candidates for studies relevant to clinical programs, but the paucity of human 
tissues and the added costs and complications involved in experiments with these tissues 
results in severe limitations in accommodating the necessary experiments. The need for human 
model systems is great especially since there are factors associated with individual donors, 
such as certain genetic disorders and diseases that might be influential to experimental results. 
All of these issues and more lead to the necessity for human model systems that are 
standardized, reliable and industrially scalable.  
These needs have driven the development of in vitro human models for preclinical drug 
development, for disease mechanism research, as well as for studies on drug efficacy, 
metabolism, and toxicity. The in vitro models provide a more repetitive and quantitative way to 
investigate the physiology of cells and tissues in drug development and discovery and can be 
more rigorously controlled in experimentation. They are also typically more cost effective and 
  2 
efficient as compared to models involving primary cultures of donor tissues and the less reliable 
animal models, while enabling the possibility of evaluating many different experimental 
conditions at the same time. 
 
Development of Ex Vivo Cultures 
Monolayer cultures have been the most commonly used models for the study of hepatic 
cells because of the ease of handling and of assaying the cultures along with the clarity of 
observing the growth and morphological changes of the cells. However, when hepatocytes are 
isolated from their natural environment in the liver and cultured in vitro on plastic, the 
hepatocytes lose their differentiated functions within less than a week (11, 12). A variety of 
media have been used in these systems, which began with media supplemented with serum.  
Serum supplemented media, used for decades, are being replaced increasingly by 
supplementation with mixtures of defined and purified hormones and growth factors that form a 
serum-free, hormonally defined medium (HDM) tailored to the cell type, the maturational lineage 
stage of interest or the biological goal(s) of the experiment. The HDM have greatly improved cell 
functions in cultures, since serum is present in vivo only when there is a wound and contains 
factors driving tissues towards scar tissue formation and, therefore, fibrotic reactions (13).  The 
differentiated cells require serum-free conditions to express their tissue-specific functions (11).  
The HDM can be optimized for cell growth, for selection of specific cell types or 
maturational lineage stages, and can be optimized for tissue-specific gene expression. The 
primary cultures of selected cell populations can be sustained in culture for up to a week in 
serum-free HDM (11).  
Additionally, homotypic and heterotypic interactions between cells have been observed 
in the co-culture of hepatocytes with non-parenchymal cells to greatly improve their survival and 
function (14-17). Co-culturing of hepatocytes with mesenchymal cells, ideally those with which 
that are partnered in vivo, has been observed to increase functions (18). More recently, 
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biomedical engineers have set up lab chips or microfluidics devices with co-culture systems 
resulting in parenchymal cells that are far more differentiated and last in culture for weeks (19). 
These are useful in microscale experiments for toxicological or pharmacological studies, but the 
cell numbers are too small to accommodate most biochemical studies.  
In addition to co-cultures with non-parenchymal cells, in vitro culture systems of liver 
have been developed that utilize specific, purified components from the extracellular matrix, 
such as collagens or fibronectin, or attempt to mimic the native microenvironment through the 
use of other biomaterials (e.g. synthesized polymers). The use of purified extracellular matrix 
components in combination with serum-free HDM can enable the cells to be functionally stable 
for 1-2 weeks (11, 20-23). Other methods include the use of substrata consisting of extracellular 
matrix proteins to coat culture surfaces or fabrication of “sandwich cultures” in which the 
parenchymal cells are placed in between two layers of matrix components (24-28). All of these 
variations of the use of matrix components are helpful to achieve greater levels of differentiation. 
The phenotypic traits of the mature cells are dependent, in part, on certain matrix components 
found in the native microenvironment of these cells (24, 29-34). The extracellular matrix 
components, and factors bound to them, regulate the gene expression of these cells as well as 
their growth and morphology.  
The methods that have seen the most success in the culturing of differentiated cells 
have been systems with 3D configurations that attempt to mimic the native microenvironment of 
the tissue in vivo as much as possible (35-37). Hepatocytes have been entrapped within a 
variety of biomaterials (38, 39). Some examples include embedding the cells within matrix 
components such as Matrigel or collagen-based hydrogels (40-42). Also, primary hepatocytes 
have been embedded in alginate and gelatin as well as in a PEG-based hydrogel (43-45).  
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Organoid Cultures 
In recent years there has been a return to organoid cultures, aggregates of epithelia and 
their mesenchymal partners that form units of ~1000 cells/unit.  These cultures survive for 
weeks and remain functional, albeit at muted functional levels 
(~5%) relative to in vivo functions.   First utilized decades ago 
particularly with respect to cultures of embryonic tissues, the 
organoid culture systems were abandoned for decades because 
of the desire to have cultures derived entirely from a cloned cell 
population and to have the advantages of visualizing the cells in 
monolayers. Many investigators are now returning to organoid culture systems due to the 
increasing recognition of the importance of the epithelial-mesenchymal interactions and their 
paracrine signals that serve to stabilize the cells and their functions (46). Studies have shown 
that these types of cultures facilitate the formation of cell configurations and polarities that are 
closer to those found in the native tissue (47).  
Formation of organoids comprised of aggregates of 
parenchymal cells, endothelial and stellate cells, have been 
observed also to improve hepatocyte survival and functions (48-
53). These categories of cells have been shown to co-exist in vivo 
and to participate in important cell-cell signaling necessary for 
proper liver functions that include homeostasis and regeneration 
(54-59). Interactions between endothelial cells and hepatocytes 
have been found to be important in the formation of vascular 
structures that lead to the morphogenesis of the liver (56, 60-62). 
Hepatic stellate cells have also been shown to participate in 
extracellular matrix synthesis and to direct signaling with 
Figure 1: Clonal LGR5-
derived Organoids (6) 
Figure 2: iPSCs-derived Liver 
Buds Co-cultured with HUVECs 
and MSCs (5) 
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cholangiocytes and with secondary effects on hepatocytes resulting in the promotion of the 
formation of various hepatic ultrastructures including desmosomes, bile canaliculi, and tight 
junctions (49-51). These cellular interactions are essential in regulating cell behavior and in 
maintaining the proper parenchymal phenotype.  
Various investigators have utilized these cellular interactions to form organoids with 
improved hepatic functions. Huch et al. cultured LGR5-positive hepatic stem cells isolated from 
fetal livers and biliary ducts of mice in a 3D system consisting of Matrigel with a culture medium 
that included the Wnt agonist RSPO1, the ligand of LGR5 that promotes hepatocyte and bile 
duct generation in vivo (6). They were able to culture these organoids for up to 8 months. After 
1-2 months, these organoids were found to express multiple hepatic-lineage and bile duct 
markers. These organoids, embedded in Matrigel, were able to attain expression of mature 
hepatocytic markers after induction with a differentiation medium that included FGF, EGF, and 
HGF. After these organoids were cultured in this medium for 13 days, the organoids achieved 
levels of functions that were about 5% of those in mature hepatocytes (e.g. albumin secretion).  
Thus, the organoids offered 3D cultures that are stable long-term and do preserve some degree 
of the functions albeit highly muted relative to that in vivo.  
Takebe et al. were able to create “liver organ buds” in vitro from human induced 
pluripotent stem cells (iPSCs) (5). The endodermal cells that self-assembled into organoids 
were committed to a hepatic fate after being embedded in Matrigel for 5-6 days. They were able 
to attain hepatic differentiation of these iPSCs by further culturing the cells in differentiation 
medium for 3-4 days. These cells were then co-cultured with human umbilical vein endothelial 
cells (HUVECs) and human mesenchymal stem cells (MSCs) and were observed to self-
organize for up to 48 hours after being seeded together. Gene expression showed that the 
iPSCs that were co-cultured expressed significantly higher levels of early hepatic markers 
compared to the iPSCs that had been differentiated to a hepatic lineage but cultured alone. The 
liver buds were transplanted into mice and were observed to connect with the host vasculature 
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within 48 hours. The hepatic cells within the liver buds proliferated at a high rate in vivo and 
were observed to form hepatic cord-like structures after 2 months. Significant levels of albumin 
secretion were observed 10 days after transplantation with albumin being secreted at an 
extremely high rate after 45 days. Gene expression analyses verified these results on the 
explanted liver bud after 60 days. The functional levels of the iPSC-derived liver buds were high 
relative to the starting points of the experiments and secreted almost double the albumin 
secreted by hepatocytes cultured in vitro but remained less than those functions of liver buds 
derived from fetal livers of 22-40 weeks old.  
Soto-Gutierrez et al. co-cultured primary mouse hepatocytes with human non-
parenchymal cells in Matrigel (62). The non-parenchymal cells included endothelial and stellate 
cell populations acquired from a variety of sources. They were found to form tube-like 
structures. The co-cultured hepatocytes were found to migrate to the tubes and remain attached 
while the hepatocytes that were cultured without these additional cell types formed independent 
organoids without any connection between them suggesting that these hepatocytes have 
tendencies to form structures similar to the sinusoids found in the native liver. When comparing 
hepatic functions, the organoids that were formed from the co-culture of the various cell types 
were found to have significantly increased albumin secretion after 4 days as compared to the 
cultures of primary hepatocytes alone. This significant increase was maintained even after 7 
days with the spheroids of hepatocytes significantly decreasing in albumin secretion after 5 
days. After a week of culture, the organoids were seen to maintain their high level of function. 
Yamada et al. co-cultured primary rat hepatocytes 
sandwiched with 3T3 feeder cells in Ba-alginate hydrogel 
microfibers that allowed the formation of heterotypic micro-
organoids in order to mimic the structure of the hepatic cords 
found in the native liver (4). The organoids remained viable after a Figure 3: Hydrogel Fibers of 
Rat Hepatocytes Co-Cultured 
with Swiss 3T3 Cells (4) 
CK18 Vimentin 
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month of culture and hepatic functions were found to be significantly increased as compared to 
traditional cultures. When compared to hepatocytes cultured on a layer of type I collagen and 
microfiber cultures with only hepatocytes, albumin secretion was significantly improved with the 
3T3-hepatocyte co-culture organoids gradually increasing in secretion levels out to 20 days and 
maintain this level for at least 50 days. The organoids were found to still be secreting albumin 
after 90 days. These results were consistent in the gene expression analysis of the organoids.  
Lu et al. utilized a hollow fiber reactor with a polysulphone-g-poly (ethylene glycol) (PSf-
g-PEG) membrane to culture primary rat hepatocytes that self-assembled into organoids along 
the hollow fibers (63). When compared to monolayer and sandwich culture, these organoids 
were found to have significantly increased albumin secretion and remained functional for at 
least 2 weeks. These findings were also verified by gene expression analysis.  
Au et al. was able to fabricate arrays of hepatic organoids from the co-culturing of a cell 
line, HepG2, transformed hepatocytic committed progenitors,  and with NIH-3T3 cells 
embedded in 3D hydrogel matrices consisting of type I collagen (64). These organoids were 
cultured for up to 4 days at which point the majority of the cells remained viable. No difference in 
albumin secretion was found in the first 3 days of culture, but a significant difference was found 
on day 4 with the cultures containing both cell types secreting much more albumin than the 
cultures of HepG2 cells alone. This confirmed the importance of the interactions between the 
epithelial and mesenchymal cells for hepatic functions. 
However, organoids are constrained to be miniscale models since large numbers cannot 
be sustained given the absence of vascular support. Novel forms of organoids that incorporate 
extracellular matrix chemistry may yield improved and a more stable differentiation of 
hepatocytes that can be scalable.  
Table 1. Comparison between Current Organoid Culture Methods
Species of 
Parenchymal 
Cells 
Species of 
Non-
Parenchymal 
cells 
Hydrogel 
Material: 
Culture 
Method 
Length of 
Time 
Cultures 
Viable 
Functionality via Albumin 
Secretion 
Level of Functions 
Relative to Cultured 
Isolated Hepatocytes 
Reference 
LGR5+ Liver 
Stem Cells 
(Mouse) 
N/A Matrigel: 
Embedded 
 
8 months d13: Differentiation Medium 7x> 
Expansion RSPO Medium  
(Biliary Types) 
 
d13: Hepatocytes 21x> 
Differentiation Medium 
Albumin Secretion: 
 
24h Hep 21x> LGR+ SCs 
D13 in DM 
(6) 
Hepatic-specific  
iPSCs  
(human) 
HUVECs 
MSCs 
(human) 
Matrigel: 
Embedded 
 
>10 days 
 
>2 months  
in vivo 
d10: Co-culture buds>Hep alone 
 
d45: Co-culture buds>>>Hep alone 
Albumin Secretion: 
 
Transplanted iPSC-LB  
d45 2x>d15 Hep 
(5) 
Primary 
Hepatocytes 
(Mouse)  
Stellate  
TWNT-1  
Endothelial 
TMNK-1  
Cholangiocytic 
MMNK-1  
(human) 
 
Matrigel: 
Embedded 
 
>1 week d1-7: Co-cultures>Hep alone 
Increased until Day 5 then decreased 
Ammonia & Lidocaine 
Metabolism:  
 
Co-cultures>Hep alone 
(62) 
Primary 
Hepatocytes 
(Rat) 
 
Swiss 3T3 
(mouse) 
Alginate: 
Microfluidic 
Hydrogel 
Fibers 
 
3 months d1-90: Increased until day 20 then 
decreased 
 
d7: Co-cultures>Hep alone 
High O2>Normal O2 
Albumin Expression:  
 
Co-cultures>Hep alone 
Fiber = Plate 
(4) 
Primary 
Hepatocytes 
(Rat) 
N/A Collagen I: 
PSf-g-PEG 
Hollow Fiber 
Membrane 
>2 weeks d14: Organoid>Sandwich>>2D Glucose Metabolism: 
 
Organoid>Sandwich>>2D 
(63) 
HepG2 
(human) 
 
NIH-3T3 
(mouse) 
Collagen I 
Digital 
Microfluidics 
>4 days d4: Co-cultures>HepG2 alone CYP3A Activity:  
 
3D>2D 
(64) 
8 
  9 
In summary, 3D liver organoid cultures are now the dominant culture system under 
consideration for industry. The long-term viability and maintenance of diverse differentiated 
functions of these cells show the importance of paracrine signaling between parenchymal cells, 
endothelia and stellate cells. Some limitations include that they can only be used, due to the 
lack of vascularization, at a micro- to miniscale basis, and that the differentiated functions are a 
fraction of those in vivo. Although all of them make use of a matrix component(s) or a crude 
matrix extract such as Matrigel, there has been no systematic exploration of the effects of 
tissue-specific matrix components or extracts.  
 
The Liver and its Maturational Lineages of Parenchymal and Mesenchymal Cells 
The liver is organized into acini, with each acinus being hexagonal and demarcated by 6 
sets of portal triads at the vertices; plates of liver cells extend from the portal triads to a central 
vein. The phenotypic traits of the cells are distinct in different regions of the liver acinus. The 
pattern of these traits constitute a 
maturational lineage of cells extending 
from the portal triads (zone 1), through 
the mid-acinar region (zone 2), and 
ending at the central vein (zone 3). The 
zonation of functions correlates with the 
maturational lineages of the cells, 
beginning with hepatic stem cells, 
located in special small channels termed 
“canals of Hering”, next to each of the 
portal triads in zone 1 (65-68). These 
Figure 4: Structural Organization of the Liver (1) 
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differentiate into diploid adult hepatocytes in zone 1, into mature hepatocytes in the mid-acinar 
zone (zone 2), and into terminally differentiated and apoptotic cells in zone 3. Zone 3 is also the 
site that is replete with macrophages, found to facilitate aspects of the apoptotic process.   
The maturational lineage stages have been defined in more detail in recent years 
resulting in recognition of at least 10 intrahepatic lineage stages (69, 70). Hepatic stem cells 
(HpSCs), which are multipotent cells, are known as intrahepatic lineage stage 1 in this 
classification system and are located within canals of Hering. They give rise to bipotent 
hepatoblasts (HBs, stage 2) that in turn produce committed hepatocytic and biliary progenitors 
(stage 3). The diploid subpopulations of the cholangiocytic and hepatocytic lineages (stage 4) 
are also in zone 1, the primary site for gluconeogenesis. The mid-acinus (zone 2) contains 
lineage stages 5-7 that can be diploid in humans (but are polyploid in old age) and are always 
tetraploid in 4-5 week old rats and tetraploid or octaploid in 3-4 week old mice; the mid-acinar 
hepatocytes are fully mature and able to regulate most tissue-specific genes (e.g. albumin, 
transferrin, tyrosine aminotransferase) both transcriptionally and posttranscriptionally. The 
pericentral zone (zone 3) contains terminally differentiated cells that are in lineage stages 8 and 
9, and apoptotic cells (lineage stage 10). Humans have terminally differentiated cells that are 
tetraploid; rats have hepatocytes that are a mix of tetraploid and octaploid; and mice have zone 
3 hepatocytes that are 16N to 32N. Zone 3 is the peak site for lipid metabolism and for 
detoxification enzymes (e.g. P450s). In summary, the plates of liver cells are comprised of 
different maturational lineage stages each one being defined by a unique set of phenotypic traits 
that include morphology, cell size, types of mitrochondria, gene expression, and ability to 
regulate a given gene transcriptionally or post-transcriptionally.  
The lineages of parenchymal cells are paralleled by lineages of partner mesenchymal 
cells. Angioblasts are associated with hepatic stem cells and give rise to endothelial cell 
lineages associated with the hepatocytes and to stellate/fibroblasts/smooth muscle cell lineages 
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associated with the biliary cells (71, 72). The paracrine signaling between the epithelia and the 
mesenchymal cells forms a gradient of factors that are lineage-stage specific. 
 
Key Phenotypic Traits of the Distinct Lineage Stages of Cells 
The different lineage stages are recognizable by specific biochemical or antigenic 
biomarkers (67, 73). The hepatic stem cells (HpSCs) express epithelial cell adhesion molecule 
(EpCAM) throughout the cells and neural cell adhesion molecule (NCAM), enabling their 
isolation by immunoselection for cells expressing both markers. They also express cytokeratins 
8, 18 and 19, a number of endodermal transcription factors (SOX9, SOX17, HES1) and low 
levels of pluripotency genes (OCT4, NANOG, KLF4). The angioblasts in association with the 
HpSCs express c-kit, CD133 (prominin), the vascular endothelial growth factor receptor (VEGF-
r) and Von Willebrand factor (8, 65-67, 74). The HpSCs account for ~0.5-2% of the parenchymal 
cells in livers of all donor ages (65). 
The HpSCs give rise to hepatoblasts and in parallel, the angioblasts give rise to the 
precursors of endothelia and stellate cells. The biomarkers for the hepatoblasts include AFP, 
albumin, EpCAM (localized now to the plasma membrane), intercellular adhesion molecule-1 
(ICAM-1), P450 A7, and a loss of the pluripotency genes and of SOX17; their mesenchymal 
partners include the stellate cell precursors that express CD146 (Mel-CAM), alpha smooth 
muscle actin (α-SMA), and desmin; the endothelial cell precursors express CD31, CD133, 
VEGF-r and Von Willebrand factor (8, 65, 66, 69). The majority (>80%) of the parenchymal cells 
in the fetal liver are hepatoblasts but they rapidly decrease in numbers postnatally. Within a few 
months of birth, their percentage is <0.01% of all the parenchymal cells (20, 65, 68, 70, 73, 75, 
76). Additionally, hepatoblasts express higher levels of albumin localized in discrete packets 
within the cytoplasm, increased levels of liver-specific genes such as the early P450s and CK7, 
ICAM-1 instead of NCAM, and have much higher levels of AFP expression (65, 77). 
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Hepatoblasts can be isolated via dual immunoselection for cells that are positive for EpCAM and 
ICAM-1 (8). 
Lineage stage 3 consists of the committed progenitors, cells that are unipotent for either 
the hepatocytic or biliary lineage. They no longer express the endodermal transcription factors 
or the pluripotency genes but instead have hepatocytic or biliary marker expression intermediate 
between that found in hepatoblasts versus adult parenchymal cells. Although present in 
significant numbers in fetal livers, they are uncommon in normal adult livers although they can 
achieve significant numbers in livers of donors with chronic liver diseases (78-80).  
The biliary committed progenitors give rise to small cholangiocytes (lineage stage 4) that 
express muscarinic acetylcholine receptor M3, histamine H1 receptor, and cystic fibrosis 
transmembrane conductance regulator (CFTR). They do not express anion exchanger 1 (Band 
3), receptors for secretin or somatostatin, nor any hepatocytic genes. Large cholangiocytes 
have more rough endoplasmic reticulum as compared to small cholangiocytes (80). These cells 
line the interlobular ducts in the portal triads and the larger intrahepatic ducts. Like small 
cholangiocytes, they express CFTR but they also express anion exchanger 1 (Band 3) and 
receptors for secretin and somatostatin. (80, 81). 
Lineage stage 4 hepatocytes, called small hepatocytes (17-21 µm) are all diploid and are 
bound together on their lateral borders enabling them to form plates or cords of cells (82-84) 
recognizable by the glucogenesis dominant in this region and for particular connexins (connexin 
28). By zone 2 (lineage stages 5-7 cells), the plates of liver cells are distinctive in their 
relationship with the endothelia that are increasingly fenestrated (that is, have gaps) allowing 
plasma to contact the hepatocytes directly. The mid-acinar cells have production of specific 
elongation factors needed to translate transferrin mRNA among other factors to produce 
detectable levels of the protein even though the mRNA is already expressed in all earlier 
lineage stages (69, 85-87). Additionally, hepatocytes at these stage produce especially high 
levels of albumin and tyrosine aminotransferase due to their peak expression of transcription 
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factors associated with the regulation of the protein (88, 89). These hepatocytes have the 
highest activities in gluconeogenesis, urea synthesis, glutathione peroxidase, and the 
metabolism of amino acids and ammonia (90).  
Hepatocytes in lineage stages 8-9 are located pericentrally (zone 3) and are in 
association entirely and only with fenestrated endothelial cells. They can synthesize DNA but do 
not undergo cytokinesis and so become polyploid, of which a subset are undergoing apoptosis 
(91, 92). The pericentral hepatocytes express albumin, transferrin, tyrosine aminotransferase, 
glutathione transferases, heparin proteoglycans and the late P450s (93). Kupffer cells are found 
in high abundance pericentrally and are in association with the apoptotic cells (92).  
 
Extracellular Matrix Composition 
The extracellular matrix (ECM) is an insoluble complex of components secreted by all 
cells and is located outside of the cells; the ECM forms the chemical scaffolding for the cells in a 
tissue or organ. These components are important for intracellular communication via cell-cell 
connections, induce the polarization of cells (94) and provide signals dictating gene expression 
and differentiation (95).  
The major components of all ECMs are collagens, which are the insoluble proteins that 
form the framework of the ECM. There are over 25 types of collagens identified. The ECM of the 
liver is typical of organs in which the majority of the collagens consist of type I, III, IV, V, VI and 
XVIII (96). Bound to these collagens are numerous other insoluble components that include 
attachment proteins (multiple forms of laminins and fibronectins) and proteoglycans. These 
proteoglycans have a core protein to which are attached glycosaminoglycan (GAG) chains, 
which are sulfated polymers of  uronic acid-amino sugar dimers (97).  There are some 
proteoglycans, such as perlecan, that are present in the ECM but are not bound to cell 
membranes. There are also forms of proteoglycans that are associated with the membranes 
such as syndecans and glypicans. All of the GAGs are chemical scaffolds for signaling 
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molecules such as growth factors and cytokines that dictate which receptor(s) these signals 
bind and/or influence facets of the signal transduction process. Also present are specialty 
molecules such as fibrillin. They are components of microfibrils to which are bound elastin, a 
key component in a tissue’s elasticity, and nidogen (also called entactin), a sulfated glycoprotein 
bound tightly to laminin (98-100). 
      The collagens are molecules consisting of 3 
amino acid chains woven together in a braid-like 
structure in the regions comprised of glycine-proline-
X. These form a triple-helical region that is very 
stable with globular domains at the ends of the 
collagen molecules and with amino acid sequences 
that are distinct for each collagen type. The 
molecules are synthesized and subsequently 
modified by posttranslational processing mechanisms 
to have one or both globular domains eliminated, 
and with various other modifications that guide 
fibrollogenesis into collagen fibers. The different 
types of collagen fibers are the result of multiple 
collagen molecules organized in fibrillar 
structures. The collagens, especially the fibrillar 
collagens, provide mechanical stability and tensile 
strength to the ECM particularly in the direction 
and orientation of the fibers (99, 101). 
Exceptions occur for the network collagens 
(e.g. collagen types IV and VI) that keep both 
Gly-Pro-X Region 
Figure 5: Fibrillar Collagens. The 3 amino 
chains can be identical (homotrimers) or 
distinct (heterotrimers).  Each of the more 
than 20 fibrillar collagen types has a unique 
amino acid sequence.  The fibrillar collagens 
offer greater mechanical support than network 
network collagens and primarily in the 
orientation of the fiber (2).   
Figure 6: Network collagens. 7S domain is 
the site to which laminin is bound. These 
collagens form a single collagen molecular 
layer adjacent to cells and offer flexible in all 
directions (3). 
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globular domains and then form a single molecular layer of a net-like structure that connects to 
cells via specific attachment proteins such as one of the 15 known forms of laminin.   Type I 
collagen has 5 molecules per fibril and confers the greatest tensile strength; it is found in sites 
requiring stability and mechanical strength. Type III collagen is chemically very similar to type I 
collagen but has fewer molecules per fibril and forms delicate fibers (also known as reticulin) 
that provide a “nesting” framework for cells. This molecule is present throughout the liver plates. 
Type V collagen is found in sites of active growth and is often in complexes with type I. Type IV 
and VI collagen form single molecular layers that are present in the basal lamina.  Type XVIII 
combines properties of collagens and proteoglycans and has bound heparan sulfate chains; it is 
associated with basement membranes of endothelia.  
The attachment proteins include multiple classes, but two of the most common are 
laminin, for which there are at least 15 known isoforms, and fibronectins, which are also found in 
multiple isoforms. Two of the major ones are tissue fibronectin, which have cell binding 
domains, and plasma fibronectin, devoid of cell binding domains and found in blood and lymph.    
 
 These various components of the ECM bind cells to specific cell receptors (e.g. 
integrins). Elastin and fibrillin are part of the microfibrils that are also responsible for many of the 
mechanical properties of tissues and bind to other ECM molecules, including some collagens 
and proteoglycans. Fibronectin is secreted by cells and is central to the stability of the ECM. 
Figure 7: Families of attachment proteins: fibronectins (a) and laminins (b). Both have cell 
binding domains and sites at which other matrix molecules can attach.  The attachment 
proteins have various signals (e.g. EGF) hardwired” into their aminoacid sequence.  Therefore, 
dissolution of these proteins releases the signals into the local microenvironment (9, 10) 
 
 
B 
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This adhesion molecule is also important in 
the cell growth and contractility that is 
dependent on cellular adhesion (102-104). 
The fibrils of fibronectin are formed by the 
polymerization and deposition of this 
molecule, which control the deposition of 
collagen I and III (102-104).  
 
Organization of the Liver ECM in Chemical Gradients Correlated with Liver Histology 
The Glisson’s capsule around the liver and periportal regions have a basement 
membrane that consists of collagens IV and VI, laminin, nidogen, and perlecan. The portal 
space interstitium contains types I, III, IV, V collagen, and fibronectin (97). These molecules 
have specifically been seen to localize around areas that include the basement membranes 
beneath the endothelial lines of hepatic arteries, portal veins, around bile ducts, lymphatic 
vessels and nerve axons (105). Collagen IV has also been found to be around the central vein 
and in the Space of Disse (105). Fibronectin is absent around the lymphatic vessels and bile 
ducts but is found throughout the liver plates (106). Elastin can be found in the vasculature and 
the Glisson’s capsule (106). Collagen IV and fibronectin are the only matrix molecules found 
across all the acini between the liver cell plates and the endothelial lining but also around the 
central vein in the sinusoidal lining (105).   
Fibrillar structures with type I, III, and V collagen have specifically been seen to localize 
around the portal triads, ductal plates, hepatic cords, framework of the sinusoids, Glisson’s 
capsule, and the canals of Hering (106). Collagen IV, laminin, and nidogen have been seen in 
the basement membrane and around the portal triads (106). The space of Disse located 
between the sinusoidal endothelial cells and the hepatocytes lacks the continuous laminin, 
perlecan, and entactin/nidogen found in the majority of basement membranes whereas type III 
 
Figure 8: The various matrix molecules aggregate to 
form an insoluble complex adjacent to cells (1) 
  17
and IV collagen along with fibronectin are abundant (105, 107). A continuous network of 
collagen I fibers connect the lobular areas to the adjacent portal tracts (97). Collagen VI fibers 
are found primarily in the portal spaces and form continuous layers in the sinusoids while 
collagen XVIII is also found in the basement membranes (97, 107).  
The liver ECM in the canals of Hering is comprised of hyaluronans (HA), non-sulfated or 
minimally sulfated glycosaminoglycans (GAGs), primarily chondroitin sulfates, along with 
minimally sulfated forms of proteoglycans (PGs).  Outside of these niches, the proteoglycans 
have sulfated GAGs that include heparan sulfates (HS) and heparins (HPs), which are polymers 
of glucuronic acid and glucosamine, as well as chondroitin sulfates (CS) and dermatan sulfates 
(DS), which are polymers of glucuronic acid and galactosamine (108, 109). Although these are 
all found throughout the liver, the HS-PGs and HP-PGs are dominant with respect to the 
hepatocytes and with the extent of sulfation increasing with proximity to the central vein. The 
CS-PGs and DS-PGs become more dominant with respect to the biliary lineages. CS-PGs and 
DS-PGs are secreted by lipocytes, while HS-PGs and HP-PGs are secreted by both 
hepatocytes and lipocytes. These PGs are localized predominantly in the Space of Disse 
between the hepatocytes and the endothelia, and are important for inducing cell polarity, 
facilitating communication via gap junctions, and in regulating tissue-specific gene expression 
(83, 110). The HS-PGs/HP-PGs specific to the liver include perlecan, syndecans, glypicans, and 
fibroglycan. Perlecan is not in contact with the plasma membrane of the cells but is known to be 
a reservoir of various signals that are bound to its GAGs; localized secretion of particular 
enzymes result in the release of signals to the microenvironment. This molecule is known to 
affect cell migration, proliferation, and differentiation by facilitating cell signaling that is mediated 
with the activation of various growth factors (101). Syndecans are proteoglycans that have core 
proteins that are transmembrane; glypicans are bound to the plasma membrane via 
phosphotidyl inositol linkages. These proteoglycans are the most active in regulating signal 
transduction processes by influencing which receptors are available for particular signals and for 
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influencing facets of the signal transduction processes that regulate cell growth and 
differentiation (101). Fibroglycan is also localized in the basement membrane and has also been 
seen to have a role in the development of the liver (110).  
 
Extracellular Matrix Gradients in Fetal versus Adult Livers 
The liver is an incredibly dynamic organ that changes throughout fetal development and 
there are variations in the proportions of matrix molecules in the fetal liver as compared to a 
mature liver. The fetal liver can be characterized as labile and is predominantly comprised of 
type III, IV, and V collagens as well as laminins, hyaluronans and minimally sulfated 
proteoglycans. Mature livers are much more stable and have a distinct matrix molecule 
composition that consist of type I, III, IV, V, VI and XVIII collagens as well as fibronectins, 
laminins, and the proteoglycans. The matrix chemistry in the stem cell niche is only partially 
defined but include hyaluronans, type III collagen, fetal forms of laminins (e.g. laminin 5) and 
minimally sulfated CS-PGs. The cells that are immediately outside of the stem cell niche (e.g. 
hepatoblasts) are associated with hyaluronans, type IV and V collagens, fetal laminins and 
minimally sulfated forms of HS-PGs. With progression across the acinar plates, there is an 
increase in more sulfated HS-PGs that qualify as HP-PGs at sites near the central vein. Such 
gradients in the matrix appear in the second and third months of gestation in humans (106, 111, 
112).  
Zone 1 has a matrix composition similar to that in fetal livers and primarily consist of type 
III and IV collagen, laminin, HA, and minimally sulfated proteoglycans including HS-PGs and 
CS-PGs (113-115). The midacinar region (zone 2) can be characterized by a decrease in type 
IV collagen, laminin, and the minimally sulfated HS-PGs with an increase in type III collagen and 
heparin PGs (115). Zone 3 is the region surrounding the central vein and contains the most 
mature hepatocytes. This zone is comprised of fenestrated endothelia with a matrix chemistry 
primarily comprised of heparin PGs (113, 115).   
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Tissue-specific Extracellular Matrix Extracts Generated by Decellularization Methods 
Organs and tissues can be decellularized to provide a matrix extract that reproduces the 
tissue-specific ex vivo environments used in directing and maintaining the differentiation of both 
mature and stem/progenitor hepatic phenotypes in vitro (8, 116-118). Isolated extracellular 
matrices, prepared by the decellularization of organs, provide important sets of these regulatory 
signals to the cells and act as a more native substratum than tissue culture plastic, purified 
individual matrix components (e.g. collagen or fibronectin), and even mixtures of matrix 
components (119-121). The importance of the interactions between the complexity of the 
extracellular matrix and cells has been confirmed and further investigated in a variety of tissues 
and organs (122-126). However, further studies need to be performed to determine how this 
decellularized matrix can be best utilized to support the ex vivo maintenance of these cells. 
Liver scaffolds generated by a variety of decellularization procedures have been recellularized 
with hepatocytes in hopes of culturing the cells in an environment that mimics the native liver as 
close as possible (127-130).  
The use of decellularized tissue in the culture of cells allows for a more natural 
representation of the various biological, chemical, and mechanical properties found in the native 
liver. The process of decellularization maintains the structural integrity of the organ while 
preserving the necessary molecular components important in maintaining cell viability and 
function in an acellular scaffold (7, 131-134). Success of these decellularization procedures has 
implications in the use of these scaffolds not only in the culture of cells but also in the future for 
organ transplantation of liver lobes prepared by using a human liver scaffolds recellularized with 
human cells and perhaps even autologous cells (135).  
The various decellularization procedures that have been developed can be classified as 
physical, enzymatic, or chemical. Some mechanical procedures include agitation, sonication, 
and freezing. Enzymatic procedures include the use of trypsin, endonucleases, and 
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exonucleases. Chemical procedures used have included acidic or alkaline solutions as well as 
ionic, non-ionic, and zwitterionic detergents among others. These procedures each result in a 
scaffold with distinct sets of matrix molecules at varying concentrations (134). Procedures that 
utilize alkaline and acidic solutions typically remove the majority of the cellular components 
while preserving the structural integrity and the collagens but eliminate important molecules 
such as the GAGs (136-138). The use of non-ionic solutions such as Triton X-100 has been 
shown to remove all the GAGs in certain tissue types (139). Decellularization with this solution 
has also led to the loss of laminin and fibronectin, cellular material remaining after treatment, 
and the alteration of certain mechanical properties (139). Ionic detergents such as SDS also 
often lead to mechanical deformation and the removal of the GAGs while preserving the 
collagens (140) but the SDS binds tightly to the matrix extract and can be toxic. Another ionic 
detergent utilized is sodium deoxycholate (SDC), a bile salt that at low concentrations is 
reasonably gentle (141, 142). CHAPS, a zwitterionic solution, changes the mechanical integrity 
of the scaffold (143).  
The procedures that have seen the most success in the decellularization of organs 
generally utilize a combination of these solutions. Uygun et al. and Ott et al. have utilized a 
combination of SDS, Triton X-100, and water to fully decellularize the heart and liver tissue 
respectively (127, 144). The decellularized heart retained most of the cross-linked type I and III 
collagens, laminin, fibronectin, and GAGs but the non-crosslinked collagens and nascent (newly 
synthesized) collagens and factors bound to them are lost. Additionally, some (but not all) of the 
structural properties were preserved. 
Decellularization of the liver with these solutions resulted in a scaffold that retained most 
of the cross-linked type I and IV collagens and fibronectin (127). However, only 50% of the 
GAGs remained and the majority of the laminin was lost. Baptista et al. utilized a combination of 
Triton X-100 with ammonium hydroxide and long washes with distilled water to fully 
decellularize the liver (7). The scaffolds retained essentially none of the non-crosslinked 
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collagen and some of the cross-linked 
type I, III, and IV collagen, laminin, and 
fibronectin. In summary, all of these 
procedures retain subsets of the matrix 
components, primarily those that can 
survive low ionic strength buffers or 
distilled water. 
The most successful procedures 
have been a protocol derivative of the 
methods of Ted Miller (145, 146), a 
collagen chemist at the University of 
Alabama and who made use of buffers 
with specific salt concentrations to keep 
collagens insoluble. He prepared extracts with high salt buffers keeping all the collagens 
insoluble and then used a stepwise dilution of the buffers to isolate specific collagen types in 
solution. This strategy was used with great success to isolate specific collagen types. Rojkind et 
al. utilized a protocol derived from these methods to isolate matrix extracts that could be used 
for cell culture (147). This sequential solubilization of the tissue resulted in a scaffold that 
retained >85% of the native collagens including the cross-linked and  uncross-linked collagens 
plus some of the nascent collagens. Frozen sections of the matrix extracts, called “biomatrices”,  
were used as substrata for the culture of liver cells and were able to keep the cells viable and 
functional for more than a year in culture. The cells did not grow unless the biomatrices were 
prepared from regenerating liver (148). 
Figure 9: Matrix scaffolds prepared by delipidation 
followed by distilled water rinses.  The procedure isolates 
the cross-linked collagens and factors bound to them. 
Most of the attachment proteins and the proteoglycans 
are missing making it difficult to get cells to attach during 
the recellularization process and requiring weeks to 
achieve differentiation of the cells.  However, the vascular 
channels are patent (7).  
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This protocol was further 
improved by modifications 
reported by Wang et al. who used 
a very gentle delipidation step that 
combined dilute sodium 
deoxycholate (a bile salt) in 
combination with phospholipase 
A2. Delipidation was achieved in 
10-20 minutes, which was then 
followed by a sodium chloride 
buffer with a concentration ranging 
from 3.4-3.5M needed to keep all 
of the collagens in the liver 
insoluble (8). The resulting 
enriched matrix extract, termed 
biomatrix scaffolds, retained >98% 
of the collagens (of all known 
collagen types in the liver and 
including the cross-linked, non-
crosslinked, and nascent forms) as 
well as all of the known adhesion molecules (fibronectin, laminin, nidogen). Also retained was 
elastin and all of the known proteoglycans. Although GAGs not bound to PGS were lost, those 
associated with the PGS were retained resulting in the ability to preserve physiological levels of 
all known cytokines and growth factors (including more than 60). Moreover, the location of the 
various factors correlated with the histology of the tissue. 
Figure 10: Biomatrix scaffolds prepared by gentle delipidation 
and high salt buffer washes. The matrix extract contains 
essentially all of the collagens (>98% of cross-linked and non-
cross-linked as well as nascent collagens) and all factors bound 
to them (fibronectins, laminins, nidogen, proteoglycans, etc.).  
Notice the complexity of the matrix and the diverse types of 
matrix components present. The vascular channels are patent.  
Cells attach within minutes and differentiate within a few days (8). 
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CHAPTER II 
 
Motivation for Studies on Imaging Techniques 
 
Tissue engineering research is a multidisciplinary effort that incorporates the use of 
resources from various fields to address specific problems more efficiently and effectively. This 
approach has enabled the research in this field to become more rigorous and has accelerated 
the progression of these technologies from in vitro and animal studies to quickly becoming 
realized in clinical applications. As these technologies are developed and improved, the 
fabrication or isolation of the biomaterials used in these studies becomes increasingly 
complicated and requires more sophisticated tools of evaluation. To properly develop advanced 
tissue engineering constructs, versatile imaging methods are needed that allow the evaluation 
and monitoring of morphological changes in the construct while acquiring functional and 
molecular information. Many current studies still utilize the traditional tools of imaging that 
include the typical histological techniques. However, these methods are limited in the 
information they can provide particularly when utilized in preclinical studies. The visualization of 
these matrix extracts with the traditional methods is done typically with an endpoint assay (e.g. 
histology, immunohistochemistry, electron microscopy) and necessitates the destruction of the 
sample. This severely limits the ability for researchers to gather information during 
experimentation. Improved imaging techniques have been developed using ultrasound and are 
being used in the evaluation of tissue engineering constructs. We demonstrate here the use of 
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such novel ultrasound technologies – ones that are non-invasive and non-destructive in the 
evaluation of biomatrix scaffolds.  
The biomatrix scaffolds that were produced by the protocols from Wang et al, 2011 were 
subjected to imaging using novel ultrasound imaging technologies developed in Dr. Paul 
Dayton’s laboratory at UNC. Biomatrix scaffolds preserve the most matrix components of any 
known scaffold preparation and are unique in preserving the components in accurate 
histological locations. In this publication, we analyzed the biomatrix scaffolds to assess facets of 
their complexity both macroscopically and at levels close to capillary beds. 
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CHAPTER III 
 
Functional Ultrasound Imaging for Assessment of 
Biomatrix Scaffolds Used for Liver Organoid Formation1 
 
Synopsis 
A novel form of 3D functional ultrasound imaging has been developed to enable 
non-destructive assessment of extracellular matrix scaffolds that have been prepared by 
decellularization protocols and are intended for recellularization to create organoids.  A major 
challenge in organ decellularization is retaining patent microvascular structures crucial for 
nutrient access and functionality of organoids. The imaging method described here provides 
statistical distributions of flow rates throughout the tissue volumes; 3D vessel network 
architecture visualization; characterization of microvessel volumes and sizes; and delineation of 
cells from portal circuits. The imaging protocol was tested on biomatrix scaffolds that are tissue-
specific, but not species-specific, matrix extracts, prepared by a process that preserved >98% of  
the collagens, collagen-associated matrix components, and matrix-bound growth factors and 
cytokines. Image-derived data are discussed with respect to assessment of scaffolds followed 
 
1This chapter previous appeared as an article in Biomaterials. The original citation is as follows: 
Ryan C. Gessner, Ariel Hanson, Steve Feingold, Avery Cashion, Ana Corcimaru, Bryant Wu,  
Christopher Mullins, Stephen R. Aylward, Lola Reid*, Paul A. Dayton*. (*co-equal senior 
authors). New Ultrasound Perfusion Imaging Techniques Enable Functional Assessment of 
Matrix Scaffolds for Human Organoid Formation. Biomaterials  2013; 34(37):9341-9351.  
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by proof-of-concept studies in organoid establishment using Hep3B, human hepatoblast-like 
cells. Histology showed that the cells attached to scaffolds with patent vasculature within 
minutes; achieved engraftment at near 100%; expressed liver-specific functions within 24 hours; 
and yielded evidence of proliferation and increasing differentiation of cells throughout the two 
weeks of culture studies. This imaging method should prove valuable in analyses of such matrix 
scaffolds. 
 
Introduction 
Liver transplantation is the primary treatment for end-stage liver disease (149). 
Currently, more than 16,000 adults and children are on the national list for liver transplants.  
Unfortunately, the number of livers available for transplantation are approximately 5-6,000/year 
(150).  An alternative to organ transplantation is to support patients using an extracorporeal liver 
assist device (LAD). A LAD is a bioreactor comprised of liver cells isolated from donor livers and 
incorporated into a network of hollow dialysis fibers that mimic blood vessels, which is able to 
connect to the patient and thus able to serve as a bioartificial liver (151, 152). Such bioartificial 
liver devices provide temporary relief for one to two weeks or until an organ is available for 
transplantation. They cannot be used longer, since liver cells seeded into all extant forms of 
bioreactors attach and deposit extracellular matrix and other cellular components onto the 
hollow fibers, causing “fouling” or clogging of the fibers’ pores, limiting the life span of the device 
(153).  
 A more robust alternative is to develop human liver organoids that can be incorporated 
into a LAD to enable hemodialysis; this provides a more stable and fully functional bioartificial 
liver in which vascular channels are provided by the native extracellular matrix components 
lined by endothelia. The organoids can be formed by preparing matrix scaffolds from 
decellularized livers and then recellularizing the scaffolds with human cells. Biomatrix scaffolds, 
a particularly rich form of extracellular matrix extract [15], can be recellularized in two stages: 
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first, the vascular channels are recellularized with endothelia through which medium and then 
blood can be perfused; and second, the rest of the matrix is recellularized with a combination of 
hepatic and mesenchymal stem cell populations that will mature into fully functional liver 
parenchymal cells along with their mesenchymal cell partners.  Current efforts are making use 
of human hepatic cell lines for human liver organoid formation to establish optimal 
recellularization protocols. Successful protocols will then be used with freshly isolated human 
hepatic and mesenchymal stem cell populations and endothelia.   
For recellularized scaffolds to yield a human liver organoid able to support patients as a 
bioartificial liver, cell functions must be comparable to those of normal human livers.  Since cell 
seeding and organoid functionality are directly related to the patency and structure of 
microvascular matrix remnants in the scaffold, there is a crucial need for non-destructive 
assessment of the structural characteristics of the scaffold, particularly its vascular matrix.  
Without adequate perfusion, the process of reseeding biomatrix scaffolds with new cells cannot 
be accomplished, since this process relies on fluid transport through the matrix remnants of the 
vascular bed for the delivery of the cells. Also, after cells have been engrafted throughout the 
scaffolds, their continued functions depend on a long-term delivery of nutrients and oxygen. For 
this reason, a method to image both the anatomy and flow within the sample in a non-
destructive manner is highly desirable. 
There are many methods currently employed to image tissue scaffolds, including 
scanning and transmission electron microscopy (SEM and TEM), optical microscopy (154), 
magnetic resonance (MR) imaging and microscopy (155), computed tomography (CT) (156), 
optical coherence tomography (OCT) (157), and Doppler ultrasound (158). The selection of any 
one modality will always yield inherent tradeoffs such as cost, invasiveness to the sample, field 
of view, resolution, acquisition time, and type of information gleaned. From this list, the imaging 
modalities that can non-invasively image a 3D scaffold with a significant thickness are MR, CT, 
and ultrasound. MR and CT are widely available in both clinical and research contexts. These 
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modalities have the best field of view, although they require expensive hardware (particularly 
MR imaging). MR can also require long image acquisition times. On the other hand, CT suffers 
from poor soft tissue contrast and can cause radiation damage to cells.  Ultrasound has many 
benefits over MR and CT in that it is real-time, relatively inexpensive, non-invasive, does not 
use ionizing radiation, and has excellent soft-tissue contrast. In addition, ultrasound is able to 
assess multiple different qualities of a tissue volume (applicable to both in vivo volumes and in 
vitro biomatrix scaffolds), including tissue structure with standard b-mode (159), mechanical 
stiffness (160), microvascular perfusion architecture (161), and parametric perfusion rate (162). 
One possible challenge hindering ultrasound’s utility for scaffold perfusion assessment to date 
has likely been the modality’s limited field of view, allowing for freehand visualization of different 
2D slices, or small 3D sub-volumes, but traditionally not visualization or quantitation of a large 
field of view. Our objective in this study was to explore the application of ultrasound to perform 
3D visualization and quantification of perfusion throughout a biomatrix scaffold. 
In these studies, we have developed a protocol to enable detailed assessment of 
vascular structural and functional characteristics within scaffolds in a non-destructive manner. 
We have had two objectives: the first has been to explore the application of ultrasound to 
perform 3D visualization and quantification of perfusion throughout an extracellular matrix 
scaffold, here being biomatrix scaffolds; the second has been to demonstrate using of an 
hepatic cell line, Hep3B, that the imaging assessments can identify scaffolds that will be 
successful for cell seeding and nutrient delivery to create human liver organoids.  
 
Materials and Methods 
Decellularization of Rat Livers  
           Wistar rats (weights 250-300 g) were obtained from Charles River Laboratories, 
Wilmington, MA, and housed in animal facilities handled by the University of North Carolina 
(UNC) Division of Laboratory Animal Management. They were fed ad libitum until used for 
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experiments.  All experimental work was approved by and performed in accordance with the 
UNC Institutional Animal Use and Care Committee guidelines. 
 The protocol for decellularizing livers to produce biomatrix scaffolds has been described 
previously (8). Images of tissue in the process of decellularization are given in the online 
supplement Figure S1, and results using this protocol are compared to results using other 
decellularization protocols (Table S1). Male rats were anesthetized with Ketamine-Xylazine, and 
their abdominal cavity opened. The portal vein was cannulated with a 20-gauge catheter to 
provide a perfusion inlet to the vasculature of the liver, and the vena cava was transected to 
provide an outlet for perfusion. The liver was removed from the abdominal cavity and placed in 
a perfusion bioreactor. The blood was removed by flushing the liver with 300 ml of serum-free 
DMEM/F12 (Gibco, Grand Island, NY). A delipidation buffer, comprised of 36 U/L of 
phospholipase A2 in 1% sodium deoxycholate (Fisher, Pittsburgh, PA) was used to remove 
plasma and nuclear membranes, and was perfused through the liver for ~30 minutes (up to an 
hour) or until the tissue became transparent.  
          This was followed by perfusion for 90 minutes with a high salt buffer (NaCL).  Solubility 
constants for known collagen types in liver are such that 3.4 M NaCL is adequate to keep them 
all in an insoluble state, along with any matrix components and cytokine/growth factors bound to 
the collagens or the collagen-bound matrix components.  The liver was rinsed for 15 minutes 
with serum-free DMEM/F12 to eliminate the delipidation buffer and then followed by perfusion 
with 100 ml of DNase (1 mg per 100 ml; Fisher, Pittsburgh, PA) and RNase (5 mg per 100 ml; 
Sigma Aldrich, St. Louis, MO) to remove any residual contaminants of nucleic acids from the 
scaffold. The final step was to rinse the scaffolds with serum-free DMEM/F12 for 1 hour to 
eliminate any residual salt or nucleases. Images are provided in Figure S1. The decellularized 
liver scaffolds were stored overnight at 40C and perfused with serum-free DME/F12 basal media 
at 3 ml/min via a peristaltic pump (Masterflex, Cole-Parmer, Vernon Hills, IL) before the imaging 
study was performed. Prior to an imaging study, the scaffold was transferred from the perfusion 
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bioreactor into the sample imaging chamber (Figure 1). When in the sample imaging chamber, 
perfusion was maintained at 4 ml/min through the matrix scaffold remnant of the portal vein via 
the same peristaltic pump.   
 
Contrast Imaging   
          An overview of the image data processing workflow is provided (Figure 2). Flash 
replenishment imaging was performed using an Acuson Sequoia 512 equipped with a 15L8 
transducer (Siemens Medical Solutions USA Inc, Mountain View, CA).  The “CPS Capture” 
software algorithm was used to measure perfusion time.  The 3D images of the liver biomatrix 
scaffold were acquired by scanning the transducer in the elevational direction using a linear 
stage and motion controller (UTS150PP and ESP300, Newport, Irvine, CA) interfaced through 
LabVIEW (National Instruments, Austin, TX) as described by Feingold et al (162). Perfusion 
images were parametrically mapped to contrast arrival times between 1 and 10 seconds. These 
images were stored in DICOM format with JPEG compression and analyzed offline in MATLAB 
(Mathworks, Natick, MA). Perfusion times within the regions of interest were assessed. 
 Acoustic angiography was performed on a prototype dual frequency probe (163) with 
imaging parameters previously described (161). The imaging system was a VisualSonics 
Vevo770 (Toronto, ON, Canada), with pulses emitted at 4 MHz at 1.23 MPa, and echoes 
received on a 30 MHz transducer with 100% bandwidth after being passed through a 15 MHz 
high pass filter to remove non-contrast signal. Three-dimensional images were acquired with the 
VisualSonics 1D linear motion stage with inter-frame distance of 100 µm to yield nearly isotropic 
voxels. Images were acquired with a frame rate of 2 Hz, with 5 frames averaged at each 
location. High resolution b-mode images were also acquired with the Vevo770 system using the 
same imaging parameters, except the transmit frequency changed to 30 MHz. After imaging, 
data was exported from the ultrasound system as 8 bit uncompressed AVIs. The microvessels 
were then segmented from these images using an algorithm originally designed for human 
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magnetic resonance angiography images, as previously demonstrated by our group (161). 
These segmentations yielded XYZ points with subvoxel spacing along vessel centerlines, with 
estimates of vessel radii at each location. These segmentations were used to assess vessel 
network architecture. 
 All three scaffold samples imaged required the registration of multiple sub-volumes for 
holistic visualization. Perfusion rate information required two sub-volumes for all samples, while 
the anatomical information and acoustic angiography data required three sub-volumes for 
sample #1, and two for samples #2 and #3. Once completed, the acoustic angiography data 
was displayed via maximum intensity projections (MIPs) (Figure 3). Anatomical b-mode data 
cannot be displayed in this fashion, so XZ slices through the merged volumes were displayed.  
 
Imaging the Biomatrix Scaffolds 
Image acquisition for each sample (Figure 4, Panels 1 and 2) required approximately 
50 minutes total, due to the small step sizes used in each case to obtain high resolution images 
(800 µm steps for the anatomical and perfusion images, and 100 µm steps for the acoustic 
angiography).  Standard grayscale ultrasound images provided reference for the scaffold 
“anatomy” but provided no functional information.  Acoustic angiography provided high-
resolution images of the branching microvasculature structure, with no tissue background.  
Perfusion imaging provided spatial distributions of local flow rates (images not shown).  All 
image sets were co-registered using major anatomical landmarks.  Total field of view for the 
regions of interest acquired was approximately 4 x 4 x 3 cm (axial x lateral x elevation) for the 
anatomical and perfusion images, and approximately 4 x 3 x 1.4 cm for the acoustic 
angiography. 
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Scanning Electron Microscopy (SEM) 
 Samples of normal rat liver versus rat liver biomatrix scaffolds were fixed with 4% 
buffered formaldehyde and examined by SEM at high vacuum (Quanta 200 Field Emission Gun, 
FEI™, Hillsborough, OR) at the Chapel Hill Analytical and Nanofabrication Laboratory on the 
UNC campus. 
 
Recellularization of Biomatrix Scaffolds 
 Biomatrix scaffolds with intact vasculature were seeded with human hepatoblast-like 
cells, Hep3B cells (ATCC® HB-8064™). These cells were introduced by perfusion through the 
matrix remnants of the portal vein via a peristaltic pump (Masterflex, Cole-Parmer, Vernon Hills, 
IL) (see Figure S3) and cultured in Hep3B medium (DMEM + 10% Fetal Bovine Serum).  
Approximately 130 x106 cells were perfused into a scaffold in steps with 20 minutes intervals. 
During each interval, 30 x106 cells were perfused at 15 ml/min for 10 minutes, followed by 10 
minutes of rest (0 ml/min). This was repeated 4 times. Once all of the cells were introduced into 
a biomatrix scaffold, the flow rate was lowered to 1.3 ml/min and the scaffolds were perfused 
with the culture medium. The medium was changed after 24 hours and again every 3 days.  
 The reseeded biomatrix scaffolds were cultured in the bioreactors (Figure S3) for up to 
14 days. After 14 days, lobes of the reseeded biomatrix scaffold were either frozen for histology 
and immunohistochemistry, or fixed for scanning electron microscopy (SEM) imaging (using the 
method noted above). Sections of the reseeded biomatrix scaffolds were assessed also by 
immunohistochemistry and immunofluorescence for cell distribution (Hematoxylin and Eosin), 
cell proliferation (Ki67) and apoptosis, as well as for albumin and urea protein expression. SEM 
images were also taken to view cell location with respect to vasculature. Antibody information 
and dilutions are provided in the supplemental materials. 
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Results 
Sample Imaging Chamber  
In order to image the delicate tissue scaffold, a chamber (Figures 1 and 2) was 
designed to allow a tissue sample to be imaged while submerged in media, since ultrasound 
imaging at the frequencies utilized requires coupling of the imaging transducer to the sample 
with liquid. The fluid bath allows for non-contact image acquisition, as opposed to gel-based 
coupling that is typical for ultrasound imaging exams, while preserving the hydration of the 
scaffold. Because there was no contact pressure between the tissue and the imaging 
transducer, tissue was not deformed during imaging; this resulted in better registrations of 
multiple sub-volumes of image data.  
The imaging chamber designed for this purpose was composed of two concentric 0.25 
inch thick acrylic cylinders, each 3 inches tall. The outer diameters of the outer and inner 
cylinders were 6 and 5 inches, respectively. The outer cylinder was mounted to the 6 X 6 X 0.3 
inch acrylic base of the imaging chamber using acrylic glue. The inner cylinder was fit to the 
imaging chamber's base over a Vaseline-lubricated silicone O-ring to allow for quick coupling 
with a tight seal. Though not implemented in this study, this O-ring design also enables bi-
directional imaging orientations (i.e. it is possible to rotate the inner chamber and image the 
contralateral side of the tissue sample). The interior cylinder served several purposes. It 
provided a frame for the tissue sample support webbing, made from 5.0 silk sutures (Ethicon, 
Somerville, NJ). This support webbing held the sample suspended in the interior of chamber. 
Additional suture was loosely tethered over the top of the tissue to prevent flotation or shifting 
during the imaging study. The interior cylinder of the sample imaging chamber also allowed for 
efficient buffer circulation but limited turbulence near the sample. 
Preliminary studies showed that the peristaltic pump, which powered flow circuit #1, 
caused a slight periodicity in the flow rate through the scaffold samples as a result of the pump's 
rotary wheel design; this affected perfusion measurements. To prevent this artifact, a pulse 
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dampener (Model 07596-20, Cole-Parmer, Vernon Hills, IL) was placed between the output 
from the peristaltic pump and the input to the sample. Preliminary studies also showed that 
contrast agent exiting the sample into the surrounding fluid after perfusing through the portal 
circuit resulted in a decrease in image quality over time as contrast agent floated between the 
imaging transducer and the sample. To prevent this, a clearance fluid circuit was implemented 
(Figure 1). This circulated the fluid surrounding the scaffold sample though a microbubble 
sequestration and destruction chamber (MSDC) before reinjection into the imaging chamber. 
The MSDC was a 2 L Erlenmeyer flask in which a 1 MHz unfocused piston transducer was 
suspended (Valpey-Fisher, Hopkinton, MA) to facilitate contrast destruction. The 1 MHz piston 
transducer was pulsed at 10 Hz with a pressure of 460 kPa via a pulser (Model 801A, Ritec, 
Warwick RI).  Under these conditions, free contrast agent in the solution flowing through the 
chamber was destroyed and thus removed from the circulating media.  Media surrounding the 
scaffold was continually pumped through this chamber at 1 ml/min using a centrifugal pump 
(Model PQ-12, Greylor, Cape Coral, FL) powered by an external DC power supply (Model 
DIGI360, Electro Industries, Westbury, NY).  Four nylon luer fittings were attached to the outer 
cylinder for coupling the sample imaging chamber to the two flow circuits. All fluid circuits used 
0.125 inch inner diameter Tygon tubing, except between the catheter entering the scaffold 
sample and the outer cylinder of the imaging chamber (0.062 inch in diameter). 
 The microbubbles used in this study were prepared as previously described (164).  
Microbubbles were introduced to the perfusion fluid circuit through a T-valve injection port 
located between the pulse dampener and the biomatrix scaffold. A 24-gauge needle was used 
to pierce the septum, and microbubbles could then be injected into the fluid circuit via a 
computer-controlled syringe pump (Harvard Apparatus, Holliston, MA). Microbubbles were 
administered into the fluid circuit at a concentration of 1.5 ×109 per mL in a 1 cc syringe and at a 
rate of 20 µL/min.  
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 Three liver biomatrix scaffolds were imaged (Figure 3), hereafter referred to as samples 
1 through 3. The left lateral lobe (LLL) of each scaffold was selected as the lobe of interest, 
because it is easily accessed for imaging. Another advantage is its narrow morphology; the 
Vevo770 has a fixed acoustic focus, and thus has a narrow depth of field (< 1 cm). Our goal 
was to provide a holistic assessment of perfusion throughout a volume of tissue, and the left 
lateral lobe was most amenable to this objective. It should be noted that the techniques 
presented here could be extended to the entire volume of tissue using a transducer with a larger 
axial field of view. Each liver biomatrix scaffold was imaged with two imaging modes: flash 
replenishment and acoustic angiography.  
 
Registration of Sub-volumes  
          Because the lateral field of view of the ultrasound transducers used for these imaging 
studies was insufficient to capture the entirety of the liver lobe of interest, multiple sub-volumes 
were acquired on each system and later registered together offline. The term “sub-volume” is 
used to describe a 3D volumetric image that does not holistically capture a tissue of interest. 
Registration of these sub-volumes was performed within the open source 3D Slicer environment 
(ver 4.2.1, National Alliance for Medical Image Computing) using the Merge module, part of the 
TubeTK extension. This module is designed to register together two images that have a small 
degree of overlap along one of the axes. When the sub-volumes were registered together using 
the Merge module, they formed a single cohesive volume for the liver lobe of interest for each 
image type (b-mode, flash replenishment, and acoustic angiography). The transform module 
was then used to register the three types of ultrasound image data to each other, creating a 
single composite 3D image for each of the livers imaged.  
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Grayscale Anatomical Imaging 
Grayscale imaging (i.e. the standard non-contrast enhanced imaging) enabled tissue 
visualization for 3-dimensional region of interest (ROI) segmentations.  These data were utilized 
to calculate tissue volumes of the left lateral lobe (LLL), which were 7.24, 5.93, and 7.79 mL for 
samples #1-3, respectively.     
 
Acoustic Angiography 
 Vessel network architecture was assessed using more than 1,700 vessel segmentations 
extracted from the acoustic angiography image data. These data were rendered in 3D and color 
coded based on whether vessels are inside or outside the manually defined tissue boundary 
(Figure 4, Panels 1 and 2). Different numbers of vessels were extracted from each sample: for 
sample #1 (N = 415 vessel segmentations), sample #2 (N = 702 vessel segmentations), and 
sample #3 (N = 671 vessel segmentations). The volumes of these vessel network 
segmentations were computed to be 142.6, 226.6, and 241.3 μl and the total lengths were 
computed to be 1.0245, 1.6177, and 1.4646 meters for samples #1, #2, and #3, respectively.  
 
The vascularity ratios were 1.97%, 3.82%, and 3.10% for samples #1, #2, and #3, respectively 
(Figure 4, Panel 1d).  Although these metrics revealed sample #1 to contain fewer perfused 
vessels (both in total volume of the vessel network, and as a proportion of total volume of the 
biomatrix scaffold) the distribution of vessel sizes were similar between all three samples 
(Figure 4, Panel 2 - top). 
 
Perfusion Imaging 
Using regions of interest as defined based on anatomical data, the perfusion values within each 
volume were assessed. Histograms of the perfused pixels within the scaffold volumes were 
computed and plotted as a function of perfusion time (Figure 4, Panel 2 - bottom). Samples #2 
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and #3 had similarly shaped histograms with similar mean perfusion times of 3.128 ± 1.923 sec, 
and 3.017 ± 1.677 sec (mean μ ± σ), respectively. Sample #1, on the other hand, had a 
negatively skewed monotonically decreasing histogram with a mean perfusion of 1.381 ± 1.328 
sec. This result was in alignment with the differences in the perfusion images, which could be 
qualitatively observed; sample #1 had a larger proportion of faster perfusing regions than 
samples #2 and #3 (Figure 4). 
 
 
Scanning Electron Microscopy of Intact Liver versus Biomatrix Scaffolds  
          Scanning electron microscopy (SEM) of liver versus biomatrix scaffolds (Figure 5, Panel 
1, 5a and 5b) indicated that the decellularization protocol preserves the liver’s histological 
infrastructure, and that the macro- and micro-vascular channels are clearly intact in the liver 
biomatrix scaffolds (see arrows). These SEM images are complemented by our prior studies 
showing that all known extracellular matrix components, including all known collagen types, are 
present and preserved at >98% of the levels found in normal liver, and that the scaffolds are 
negligible for nucleic acids and for cytoplasmic components (8).  All known matrix components 
in liver versus scaffolds were assessed by immunohistochemistry and found to be in their 
correct histological sites, meaning that the liver acinar zonation (zones 1-3) is  preserved in 
terms of gradients of matrix components (8, 115). 
 
Engraftment Efficiency of Scaffold Recellularization 
          As a proof-of-concept towards human liver organoid formation, biomatrix scaffolds with 
patent vasculature were reseeded with approximately 130 x 106 Hep3b cells, human 
hepatoblast-like cells of an hepatic cell line (ATCC® HB-8064™). This cell line was established 
by Barbara Knowles and associates from a tumor from an 8-year old patient.(165) and has been 
extensively characterized with respect to liver-specific gene expression by Darlington and 
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associates (166). The Hep3B cells were introduced into the biomatrix scaffold by perfusion 
through the matrix remnants of the portal vein using a peristaltic pump.  The cells attached 
within minutes, and engraftment efficiency was near 100% by the end of the seeding process.  
 Over the course of 14 days, the medium from bioreactors with reseeded scaffolds was 
collected at varying time points and assayed by ELISA for secreted products (Figure 6). At the 
end of the 14 day culture period, scaffolds were evaluated by SEM, histology and 
immunohistochemistry. SEM images (Figure 5, Panel 1) show cells that have engrafted onto or 
into the biomatrix scaffold. Hematoxylin and eosin stained sections revealed a wide cell 
distribution throughout the scaffolds (Figure 5, Panel 2, 5a). The seeded cells actively 
proliferated throughout the 14 days of culture, as demonstrated by Ki67 staining (Figure 5, 
Panel 2, 5b), but they did not show any evidence of apoptosis (data not shown).  In addition, the 
reseeded cells expressed liver-specific proteins in patterns correlated with their known locations 
in the normal liver acinus in vivo.  Albumin (Figure 5, Panel 2, 5c) was found in all of the cells 
but at higher levels in regions of the scaffolds correlated with acinar zones 2 and 3, whereas 
epithelial cell adhesion molecule, EpCAM (Figure 5, Panel 2, 5d), was expressed only by cells 
clustered near the matrix remnants of portal triads, acinar zone 1.  EpCAM is a marker of 
hepatic stem/progenitors (8). Hep3B cells have phenotypic traits indicating that they are 
hepatoblast-like (166); normal hepatoblasts are found only in zone 1 of the pediatric and adult  
liver acinus, and are at a lineage stage in which EpCAM is a key phenotypic trait.   
 
Discussion 
We describe a method of imaging for the evaluation of matrix extracts prepared by 
decellularization of tissues. Our techniques may provide important information regarding 
vascular patency, which is particularly important if such scaffolds are to be used as substrata for 
cell populations as part of organoid formation.  The ultrasound images described here provide 
insights into the complexity of the matrix remnants of the liver architecture and of the vascular 
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channels.  The dimensions of the channels can be quantified precisely using these ultrasound 
technologies and corresponding segmentation algorithms, enabling the identification of 
categories of blood vessels for which such dimensions are known (up to 100 μm).  Furthermore, 
these techniques provide a non-destructive method to assess vascular functionality. 
When using ultrasound, contrast agents are utilized to image and quantify flow in 
microvessels that is due to the poor acoustic contrast from blood.  Microbubble contrast agents 
are the predominantly used vascular contrast agent for ultrasound. They are micron-sized lipid 
encapsulated gaseous spheres which, when immersed in a fluid, provide a strongly reflective 
interface and thus a high degree of contrast in an ultrasound image. Microbubble contrast 
agents (diameters typically between 1-5 µm) are much larger than vascular fenestrations, which 
allow them to remain within the luminal space. At the same time, they are small enough to pass 
through capillary beds. Since their rheology is similar to red blood cells (167), they are a suitable 
contrast agent for spatial mapping of vascular channel networks within biomatrix scaffold 
networks, thereby serving as surrogate markers for mapping cell movement within the scaffold.  
In addition to traditional “grayscale” ultrasound to provide reference images of the 
scaffold physical structure, two different contrast enhanced ultrasound techniques were utilized 
in this work to provide functional information about biomatrix scaffold microvasculature. The first 
technique, referred to as “flash replenishment”, or “dynamic contrast-enhanced perfusion 
imaging” (DCE-PI), allows relative blood perfusion to be spatially mapped by assessing the 
speed at which contrast agents refill a sample volume after clearance (168).  While this 
technique is not new, it has not previously been performed in this type of scaffold imaging 
application.   
The other contrast imaging approach implemented in this study is a technique we refer 
to as “acoustic angiography”. This newly developed imaging method differs from traditional 
ultrasound imaging in that it is designed to visualize vascular and microvascular structure at 
high resolution rather than tissue anatomy (163, 169).  Unlike flash replenishment, acoustic 
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angiography does not yet have the ability to parametrically map perfusion rates. However, it can 
provide detailed visualization of vessel architecture and provide a high resolution dataset from 
which vessels can be segmented and quantitatively mapped (vessel network volume, length, 
etc.).  High resolution acoustic angiography requires a new type of transducer developed by our 
lab with collaborators in F. Stuart Foster’s group at the University of Toronto, Sunnybrook (163) 
that is not yet available on commercial ultrasound systems. The protocol utilized for this work 
involves three imaging scans: the first defines the scaffold’s physical structure (anatomy) with 
standard “b-mode” or grayscale ultrasound as is commonly used clinically; the second maps 
vessel architecture with high resolution acoustic angiography for vascular network visualization 
and quantitation; the third maps perfusion rates with flash replenishment. All three studies could 
be performed sequentially with appropriate system hardware. 
The analyses of these scaffolds by imaging modalities provide evidence for the 
complexity of the matrix remnants of the liver architecture and of the vascular channels, as well 
as evidence of the scaffolds’ biological efficacy. These analyses also provide assistance with 
recellularization protocols.  The dimensions of the channels can be quantified precisely using 
these ultrasound technologies and corresponding segmentation algorithms; this enables 
identification of categories of blood vessels for which such dimensions are known.   
From a quantitative standpoint, sample #1 was noticeably different from samples #2 and 
#3 in both the acoustic angiography and perfusion images.  Sample #1 illustrated a similar 
vessel size distribution to the other two samples, but showed a grossly reduced perfusion rate. 
This was due to a defect in sample #1 – the scaffold was damaged, resulting in several low 
resistance outlets for flow exiting the system. Although we were not able to perceive this 
damage prior to imaging, it was clearly reflected in the functional data. One perforated outlet 
was clearly visible within the acoustic angiography image set (Figures 3 and 4, Sample 1, 
yellow arrow).   
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Furthermore, during contrast infusion, it was possible to delineate vessels as part of 
either the hepatic or portal circulatory networks within the tissue volume (Figure 3, white vs. 
black arrows, respectively). Because contrast was infused though the portal vein, the hepatic 
circuit did not contain contrast and thus was not visualized under acoustic angiography. When 
the b-mode volumes were registered to the acoustic angiography volumes, flow voids in the b-
mode, which were not perfused within the acoustic angiography dataset, could be classified as 
components of the hepatic circuit.  Alternatively, we could have perfused the hepatic and portal 
circuits separately, although this was not done in our experiments for simplicity. 
The ultrasound approaches we describe offer a non-destructive, high-resolution, and 
potentially inexpensive technique for visualization of scaffold perfusion. Additionally, these 
approaches offer a better depth of penetration into the scaffold than optical imaging 
approaches, allowing for the visualization of the entirety of the LLL (at the expense of both axial 
and lateral resolution, which is worse than systems imaging at optical wavelengths).  
 While the advantages of this protocol are numerous, there are also several drawbacks to 
this approach. Currently, the imaging technology presented for the Acoustic Angiography vessel 
mapping is not commercially available.  Also, while several groups have made strides toward 
calibrating flash replenishment imaging against gold standards for perfusion rate (168, 170), the 
technique currently provides only relative quantitative measures for perfusion. This is adequate 
for assessing differences in regions within a given sample, such as would be necessary for 
identifying pockets of occlusion. It does not yet allow determination of absolute flow rates (mL·s-
1·cm-3) within the scaffold without prior calibration based on the tissue volume.  Finally, our 
technique was relatively slow, due to the 1-D form factor of our transducers, which were able to 
image only a single 2-D image slice at a time and required us to mechanically scan the 
transducers across the tissue volume. The 2-D matrix ultrasound transducers now in 
development are able to acquire entire image volumes at a much higher frame rate, although 
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transducers required to perform real time 3D contrast imaging at the resolution described here 
are not yet commercially available.  
 The rapid and successful recellularization of the scaffolds with the Hep3b cells 
demonstrated the patency and functionality of the matrix remnants of the vascular network. It is 
interesting that, although the vascular walls remain sufficiently patent to constrain 1-5 micron 
microbubble contrast agents, the cells were still able to cross the matrix remnants of the 
vascular channels and engraft into all parts of the matrix, including that associated with 
parenchymal cells (Figure 5, Panel 1, 5c). It is unclear how the cells were able to engraft after 
seeding by perfusion into a decellularized liver, since the matrix remnants of the vascular 
channels were intact.  Many researchers who have successfully seeded cells into decellularized 
organs used decellularization protocols that destroyed facets of the vascular matrix (128).  Of 
those using protocols resulting in patent vascular channels ((7), it has never been explained 
how the cells are able to breach patent vascular matrix walls and engraft.  Baptista et al. (7) 
hypothesized that their method of decellularization by harsh detergents followed by distilled 
water perfusion may have caused structural damage to the vascular architecture such as 
thinning of the matrix or creating small holes; this might, in turn, have allowed cells to migrate 
across the permeabilized walls.  
We have confirmed that our decellularization method results in intact scaffolds without 
evidence of a defect: there were no breaches of the vascular matrix greater than 5 microns prior 
to seeding. An alternative explanation for the cells’ ability to breach matrix walls and engraft 
derives from hepatocyte transplantation studies (171, 172). In these studies it was shown that 
sinusoidal endothelial cells can shift to allow the hepatocytes access to larger fenestrae through 
which they achieve access and integrate into the parenchymal cell plates. SEM imaging of our 
reseeded scaffolds suggest that cells are attaching to and engaging the matrix and perhaps are 
able to squeeze through residual fenestrae left behind after decellularization (Figure 5, Panel 1, 
5d, arrows).  
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Non-destructive 3D perfusion imaging of decellularized organs and tissues could have 
significant value in tissue engineering investigations and also in tracking recellularization. 
Contrast ultrasound techniques have been shown to have utility in measuring microvasculature 
structural information and relative flow rate correlated with anatomical orientation in tissue 
scaffolds. The recellularization studies presented here indicate that cells are successfully being 
delivered and engrafting into the matrix remnants of the liver parenchyma by perfusion seeding 
(Figure 5, Panel 2). This perfusion seeding method is only possible in a patent vascular 
network, which is confirmed through the use of this high resolution acoustic angiography 
technology. Ongoing current studies include the correlation of structural information, such as 
vessel diameters, perfusion rates, local fluid shear rates, and patency with the gold standard of 
histological data after recellularization procedures are complete. Also, ligand-bearing 
microbubbles could be implemented to perform 3D ultrasonic molecular imaging, which can be 
used to spatially map specific regions of cell attachment and cell differentiation using 
biomarkers (161) and thus could be used to detect spatial distributions of different types of cells 
or varying biological states of cells in the scaffold. 
The imaging method is essential for evaluation of scaffolds to be used for organoid 
formation.  Extracellular matrix scaffolds prepared by decellularization protocols are central to 
the strategies for organoid formation, since individual and purified matrix components give only 
partial effects in induction and maintenance of differentiated cells. Efforts to isolate successful 
matrix scaffolds have dominated recent investigations (7, 127, 128, 173-176).  All of the 
protocols have proven successful in isolating matrix extracts dominated by cross-linked 
collagens. However, most do not generate scaffolds with patent vasculature (128, 173), or they 
yield scaffolds in which uncross-linked, nascent collagens and associated matrix components 
are lost (7). The protocol we present here preserves both the cross-linked and the uncross-
linked nascent collagens and preserves more of the adhesion molecules, proteoglycans and 
growth factors/cytokines that are bound to these matrix components (8).  The proof-of-principle 
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studies with Hep3B cells indicate that the richer matrix extracts such as the biomatrix scaffolds 
confer very rapid attachment (within minutes), near 100% engraftment, and significant induction 
of tissue-specific functions (to the extent possible with a transformed hepatic cell line).  
Human liver organoids are being established for use as bioartificial livers through which 
a patient’s blood can be perfused for detoxification and synthesis of critical liver-specific 
products.  We have previously shown that normal liver cells bound to frozen sections of 
biomatrix scaffolds and maintained in a serum-free, hormonally defined media designed for 
mature cells are fully functional and stable ex vivo for months (8).  If this proves true for the 
scaffolds used intact (i.e. not as frozen sections) for organoid formation, when these scaffolds 
are recellularized with freshly isolated human cells they will offer opportunities for liver-assist 
devices for patients. They also will offer the potential to generate grafts for transplantation into 
patients.   
 
Conclusions 
Non-destructive 3D perfusion imaging of decellularized organs and tissues has 
significant value in tissue engineering investigations and also in tracking recellularization 
processes of matrix scaffolds in organoid formation. Contrast ultrasound techniques have been 
shown to have utility in measuring microvasculature structural information and relative flow rate 
correlated with anatomical orientation in tissue scaffolds. The recellularization studies presented 
here indicate that cells are successfully being delivered and engrafting into intact scaffolds by 
perfusion seeding. This perfusion seeding method is only possible in a patent vascular network, 
a finding that is confirmed through the use of this high resolution acoustic angiography 
technology.  
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Figures and Tables 
Figure 11. Schematics for the sample imaging chamber. a) Assembled sample imaging 
chamber and b) exploded view of the sample imaging chamber. c) A top-down cartoon 
schematic illustrating the two flow circuits in the setup. Flow Circuit 1 provided perfusion and 
microbubbles to the liver scaffold, while Flow Circuit 2 provided continuous circulation through 
the microbubble sequestration and destruction chamber (MSDC) to remove contrast excreted 
from the sample. 
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Figure 12. The orientation of the biomatrix scaffold sample as viewed from above with the 
following visible lobes labeled: a) left lateral lobe (LLL), inferior right lobe (IRL), anterior caudate 
lobe (ACL), posterior caudate lobe (PCL), superior right lobe (SRL), and median lobe (ML). The 
LLL was the lobe imaged in this study. Lobes were identified in this figure via an available 
surgical guide. b) Orientation of the imaging sub-volumes relative to the tissue sample. XY 
dimensions were lateral and axial axes within the ultrasound coordinate space, with the Z-axis 
being the elevational scan direction. c) Schematic explaining the registration of multiple 3D 
volumes from three distinct ultrasound imaging approaches into the final composite volume.  
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Figure 13. A compilation of image data acquired of the three biomatrix scaffold samples. Yellow 
arrow indicates location of sample #1, which was perforated and thus leaking microbubbles. 
Each row was acquired with the following imaging modes (from top to bottom): Acoustic 
angiography, semi-automated segmentations from acoustic angiography data, and b-mode. 
White and black arrows on the b-mode images indicate vessels identified as part of either the 
portal or hepatic circuits, respectively.  
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Figure 14, Panel 1. a-c) 3D renderings of the biomatrix acoustic angiography data. Color is 
defined as either inside (green) or outside (purple) of the manually defined tissue border. d) 
Quantitative assessments of vascular network volume, length, and vascularity ratio. Data are 
normalized to sample #1.  
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Figure 14, Panel 2.  Perfusion comparisons between the three liver scaffolds evaluated from 
the flash-replenishment imaging. (Top) Area normalized vessel size histograms computed from 
the vessel segmentations.  (Bottom) Area normalized perfusion rate histograms.  
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Figure 15, Panel 1. Scanning Electron Microscopy (SEM)  
a) Normal adult rat liver fixed with 4% paraformaldehyde and subjected to SEM. 
b) Normal rat liver biomatrix scaffold. The major and minor vascular channels are evident in 
both the liver and in the scaffold.  Empty spaces are visible where parenchymal cells 
previously resided (thin arrow).  Major vascular channels are also visible (thick arrow).  
c) Low magnification image of rat liver biomatrix scaffold reseeded with Hep3b cells.  Large 
numbers of cells are found bound to the matrix throughout the scaffolds.  This 
attachment occurs within minutes of seeding the cells and results in near 100% 
engraftment by the end of the seeding process. 
d) Higher magnification image of rat liver biomatrix scaffold showing Hep3b cells that have 
attached, spread and are forming classic cellular extensions and connections with each 
other. They engage (thick white arrow) the lumen of the vessel wall and perhaps pass 
through the fenestrae (thin white arrow) that remain following decellularization. 
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Figure 15, Panel 2. a) Hematoxylin and eosin stained sections revealed a cell distribution 
throughout the biomatrix scaffolds.  b) The seeded cells actively proliferated through day 14, 
demonstrated by Ki67 staining (seen in magnified version in b’). c) The Hep3b cells expressed 
peak albumin levels (albumin=green, DAPI=blue) in regions of the matrix scaffolds correlated 
with zones 2 and 3 of the liver acinus.  d) Cells bound to matrix remnants of the portal triads 
(zone 1) expressed albumin more weakly than elsewhere on the matrix.  By contrast, EpCAM 
expression was quite strong in the cells bound in these regions but weak or negligible if in 
matrix regions associated with zones 2 and 3 (EpCAM=green, DAPI=blue). This is surprising, 
given that the test cells are a cell line and yet they apparently still have the capacity to show 
some degree of zonation of functions if bound to specific regions of the biomatrix scaffolds.   
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Figure 16.  Measurements of albumin and urea secretion by Hep3B cells seeded in biomatrix 
scaffolds (n=3) and cultured over a 14-day period. Levels are normalized to the number of initial 
number of cells seeded into the scaffold. Symbols indicate media collection over 24 hours ($), 
48 hours (x), 72 hours (*), and 96 hours (+). Statistical analyses were unable to be performed, 
and, therefore, raw data are presented. 
 
  
Online Supplement 
1. Media and Solutions 
All media were sterile-filtered (0.22-μm filter) and kept in the dark at 4°C before use. To keep collagens stable, the pH of the 
perfusion media for matrix scaffold preparation was kept at 7.5-8.0. DME/F12 (Gibco/Invitrogen, Carlsbad, CA) was used as the 
basal medium. All reagents except those noted were obtained from Sigma (St. Louis, MO). 
 
1.1 Kubota’s medium (KM):   
KM was designed originally for hepatoblasts (177) and now has been found effective for human hepatic stem cells and 
progenitors (8, 65, 74, 76), and for biliary tree stem cells and progenitors(178, 179), including pancreatic committed progenitors(180).  
It consists of any basal medium (here being RPMI 1640) with no copper, low calcium (0.3 mM), 10-9 M Selenium, 0.1% BSA, 4.5 mM 
Nicotinamide, 0.1 nM Zinc Sulfate heptahydrate nd), 10-8 M hydrocortisone, 5 µg/ml transferrin/Fe, 5 µg/ml insulin, 10 µg/ml high 
density lipoprotein, and a mixture of free fatty acids that are added bound to purified human serum albumin.  Details of its 
preparations are given also in a recent methods review(11). 
1.2 Hormonally defined media for differentiation (11):   
Supplementation of KM further with calcium to achieve 0.6 mM concentration,  1nM tri-iodothyronine (T3), 7 ng/ml glucagon, 
10-12 M copper. The cells were seeded in this medium, supplemented also with 5% FBS (HyClone, Waltham, MA), and switched to 
serum-free conditions thereafter. In parallel experiments, cultures were kept in the medium with 5% FBS throughout, but the 
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presence of serum was found to cause the cells to lose differentiated functions over time.  The highly functional cultures lasting 8 
weeks or longer were achieved using a serum-free differentiation medium with William’s Medium as a base, together with the 
supplements for Kubota’s Medium and those above. The soluble factors requirements are less than normal for cultures on other 
substrata, given that so many of the factors are bound to the matrix scaffolds; thus, for example, EGF, FGF, and HGF, are classic 
factors needed for mature hepatocytes. 
1.3 Matrix scaffolds:  
Protocols to decellularize organs differ among labs resulting in scaffolds with differing subsets of the tissue’s matrix 
molecules. Those utilizing matrix-degrading enzymes (128, 174), low ionic strength buffers (127) or distilled water (7) result in 
scaffolds with significant losses of matrix components. The losses limit recellularization, nutrient delivery, cell growth and 
differentiation (99, 181). Various methods (e.g. perfusing scaffolds with purified matrix components) can facilitate cellular 
engraftment. However, the extent of differentiation of the recellularized scaffolds (e.g. albumin and urea secretion) is very low relative 
to that for normal livers. See Table S1 for comparisons.
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Table 2: Comparison of Protocols used in Decellularization of Livers 
 
Decellularization method Analysis of Scaffold Matrix Chemistry Effects of the Scaffold on Cell Functions References 
 
Perfusion initially with 
distilled water followed by 
Triton X-100 or SDS  
 
Patent vasculature evaluated by dextran 
beads or corrosion casting but possible 
thinning of the walls and small holes in the 
lumen. Histological confirmation of 
retention of cross-linked collagens.  
However significantly decreased content of 
fibronectins, laminins elastin, decorin and 
sulfated glycosaminoglycans (GAGs), and 
proteoglycans 
 
To achieve significant cell attachment,  
investigators used either Matrigel, adding 
attachment proteins into the recellularization 
buffers, and/or long periods of time for cell 
seeding. Human fetal liver cells achieved 
partial hepatic differentiation. Human fetal 
hepatocyte function was not significantly 
different from static 2D cultures. 
 
(7, 176, 182, 
183) 
Perfusion initially with Triton 
X-100 and/or SDS followed 
by saline solutions.  
Vascular patency was determined by 
corrosion casting or not at all. Cross-linked 
collagens were retained but much less 
than in native tissue. Decreased amounts 
of fibronectin and elastin were found by 
Western blots or histology. Almost all GAG 
content was diminished by 
decellularization. SDS causes much more 
significant loss of matrix molecules as 
compared to Triton X-100. It also binds 
very tightly to collagens and can make the 
scaffolds toxic to cells. 
Approximately 90% of cells adhered within 24 
hours. Cells showed damage, as evaluated 
by lactate dehydrogenase release, for several 
days following reseeding. Cumulative albumin 
and urea levels were somewhat greater then 
static 2D cultures. 
(128, 174, 
184-186) 
Freezing/thawing of tissue 
and then perfusion with 
either trypsin/EDTA or SDS. 
This was followed by 
perfusion with Triton X-100 
Histology confirms presence of collagen I 
and IV, laminin and fibronectin. Only 
partial retention of growth factors. 
Corrosion casts were used to confirm 
patent vasculature. 
Cell attachment was achieved in 40 minutes 
but it took several days for cells to leave the 
vasculature and distribute throughout the 
matrix associated with the parenchyma. 
UDP-glucuronosyl transferase and Glucose-
6-phosphatase expression, and LDH release 
were found at day 2.  Transplanted for 8 
hours in vivo as an auxiliary liver.  
(127, 132) 
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Matrix scaffolds.  
Any basal medium is 
perfused in order to remove 
blood. Then the tissue is 
perfused with low 
concentrations of sodium 
deoxycholate used in 
combination with 
phospholipase A2; results in 
very rapid delipidation (~30 
minutes).  This is followed 
by perfusion with high salt 
buffers (with NaCL at a 
concentration chosen to 
ensure insolubility of those 
collagen types identified in 
the tissue).  This is followed 
by nuclease treatment, 
prepared in basal media, to 
eliminate residual nucleic 
acids 
Scaffolds contain (qualitatively) all known 
matrix components (collagens, 
fibronectins, laminins, nidogen, elastin, 
proteoglycans) found in the tissue in vivo.  
The scaffolds have >98% of the collagens 
and all of the collagen types found in the 
tissue. Glycosaminoglycan/ proteoglycan 
types and amounts are near normal.  
Growth factor array analyses indicate that 
all of the known growth factors and 
cytokines are present at physiological 
levels and bound to the matrix.  All matrix 
and growth factors/cytokines are in 
accurate histological locations. 
Cells attach to scaffolds within seconds to 
minutes.  Engraftment in intact scaffolds is 
near 100% within 24 hours of perfusion and 
with distribution to all parts of the scaffolds. 
Tissue-specific functions occur within a few 
hours.  Optimized extent of differentiation 
occurs within a few days.  
Studies on normal hepatocytes bound to 
frozen sections of scaffold indicated that 
tissue-specific functions are similar to those 
of freshly isolated liver cells and stably 
remain so for more than 8 weeks. Studies on 
normal hepatic stem cells indicated that they 
bind to frozen sections of scaffold within 
minutes, proliferated for 2-3 days, then 
differentiated to fully mature liver cells by 
~day 6-7 and finally remained stably 
differentiated for months. 
 
 
 
 
 
 
 
(8) 
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2. Decellularization of livers  
2.1 Animals:  
Wistar rats (weights 250-300 g) were obtained from Charles River Laboratories, Wilmington, MA, and housed in animal 
facilities handled by the UNC Division of Laboratory Animal Management. They were fed ad libitum until used for experiments. All 
experimental work was approved by and performed in accordance with the UNC Institutional Animal Use and Care Committee 
guidelines. 
 
2.2 Decellularization protocol:  
The protocol for decellularizing livers to produce matrix scaffolds has been described in prior publications(8). Male rats were 
anesthetized with Ketamine-Xylazine, and their abdominal cavity opened. The portal vein was cannulated with a 20-gauge catheter 
to provide a perfusion inlet to the vasculature of the liver, and the vena cava transected to provide an outlet for perfusion. The liver 
was removed from the abdominal cavity and placed in a perfusion bioreactor. The blood was removed by flushing the liver with 300 
ml of DMEM/F12 (Gibco, Grand Island, NY). Delipidation (36 U/L of phospholipase A2 in 1% sodium deoxycholate; Fisher, 
Pittsburgh, PA) was used to remove plasma and nuclear membranes. This delipidation buffer was perfused through the liver for 1 
hour or until the tissue became transparent. This was followed by perfusion for 90 minutes with a high salt buffer.  Solubility 
constants for known collagen types in liver are such that 3.4 M NaCL is adequate to keep them in an insoluble state. The liver was 
rinsed for 15 minutes with serum-free DMEM/F12 to eliminate the delipidation buffer; this was followed by perfusion with 100 ml of 
DNase (1 mg per 100 mL; Fisher, Pittsburgh, PA) and RNase (5 mg per 100 mL; Sigma Aldrich, St. Louis, MO) to remove any 
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residual contaminants of nucleic acids from the scaffold. The final step was to rinse the scaffolds with DMEM/F12 for 1 hour to 
eliminate any residual salt. Images are provided in Figure S1. The decellularized liver was stored overnight at 40C and perfused with 
media at 3 ml min-1 via a peristaltic pump (Masterflex, Cole-Parmer, Vernon Hills, IL) before the imaging study was performed. Prior 
to an imaging study, the scaffold was transferred from the perfusion bioreactor into the sample imaging chamber (Figure 1). When in 
the sample imaging chamber, perfusion was maintained at 4 ml min-1 through the portal vein via the same peristaltic pump.   
 
3. Further details on imaging technologies  
3.1 Validating imaging consistency:  
Microbubble buoyancy and floatation within syringes is known to cause a variation in contrast concentration over time (187) in 
long-term infusion studies. To mitigate this effect, the syringe was gently agitated throughout the imaging procedure as described 
previously (187). To characterize the degree to which this affected the consistency in the reported perfusion data extracted from the 
image data, a study was performed in which the transducer was fixed at a single location and flash replenishment images were 
acquired approximately every minute for 30 minutes. The data were exported to MATLAB for analysis. A region of interest (ROI) was 
defined around the perimeter of the lobe being imaged. Two quantities were assessed at each time point within the ROI: the total 
number of perfused pixels; and the average perfusion value. Two scaffolds were used for this study. The first was imaged with the 
non-agitating protocol susceptible to microbubble floatation. After data were analyzed offline, a second liver scaffold was imaged to 
observe the effects of syringe agitation on perfusion assessment consistency. Results illustrated a substantial improvement in 
repeatability of measurements with the syringe mixing strategy (Figure S2). 
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3.2 Assessing liver matrix scaffold perfusion:  
Because the two perfusion imaging modes implemented in this study (acoustic angiography and flash replenishment) were 
acquired on different ultrasound systems, an initial registration step was necessary prior to merging the volumetric datasets in the 
same coordinate system. This registration step was performed via a rigid transform within the Slicer Transforms module. The lobe of 
interest could then be manually segmented, and the same ROI could be used for all three datasets. The segmentation of the LLL 
was performed in Matlab as previously described (164). The volume of the liver lobe was measured in Slicer by creating a Model 
from the binary 3D ROI and using the Label Statistics module to sum the voxels occupied by the liver lobe. Because the 
segmentation and registration process was performed entirely offline, it was impossible to re-collect the ultrasound data of a scaffold 
if it became clear that small portions of the tissue were not imaged. In these cases, ROIs were defined to the edge of the available 
image data, or across regions of tissue if it was obvious to the viewer what path the tissue boundary was taking.  
 Each voxel within the flash replenishment images represented a spatially localized estimate of perfusion speed. To assess 
perfusion throughout the volume of tissue, all values were vectorized and histograms were created for each sample. These perfusion 
histograms were binned by perfusion time, and area was normalized by total perfused voxels (i.e. the integral of the histogram was 
set to unity). The segmentations extracted from the acoustic angiography images were used to compute total length and volume of 
the vessel network, vascularity ratio (volume of vessel network/volume of liver lobe). The volume of each discretized location in the 
segmented vessel network was computed and summed to yield total vessel network volume and length. The proportion of the vessel 
network occupied by vessel segments of a range of radii between 50 um (minimum voxel size) and 500 um was computed. 
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3.3 Limitations:  
During the offline registration and segmentation processing steps, it was discovered that some portions of the LLL were 
excluded from analysis. This was due to the transducers’ form factors being too large to image the portions of the scaffold tissue 
close to the sample imaging chamber’s wall (as shown in Figure S3 b-mode images for samples #1 and #2). We estimate this lack of 
image data to result in relatively minor errors in ROI definition, and thus relatively small errors in the estimates for perfusion since the 
periphery of the LLL would be most affected. Since the periphery of the liver’s lobes are predominantly occupied by slowly perfusing 
vasculature (188), the mean perfusion values reported via these manual segmentations will not be affected by the exclusion or 
inclusion of a small proportion of this region of tissue. Nonetheless, these errors are preventable by adjusting the experimental 
system.  
 
 
 
 
 
 
 
 
 
  
Supplemental Figures and Tables 
 
Table 3. Biological Assays Used to Evaluate the Reseeded Matrix Scaffolds with Hep3B cells 
Reagent Supplier Dilution Factor 
Ki67 abcam (#ab16667) 1:100 
Albumin abcam (#ab2406) 1:200 
EpCAM Thermo Scientific 
(#MS-181-P1) 
1:250 
Human Albumin ELISA Quantification 
Set 
Bethyl Laboratories, Inc. 
(#E80-129) 
 
QuantiChrom Urea Assay Kit BioAssay Systems 
(#DIUR-500) 
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Figure 17. Decellularization process:  
    
Top: Flushing liver with a serum-free basal medium (e.g. DME/F12) 
to remove blood. 
 
 
   Middle:  Delipidating with phospholipase A2 (PLA2) and then with PLA2 
combined with deoxycholate; rinsing with serum-free DME/F12; perfusing 
with 
3.4 M high salt buffer (salt concentration dictated by collagen types in the 
tissue), with soybean trypsin inhibitor, with all kept at a pH of 7.5-8.0; 
rinsing to remove salt.   
 
   Bottom: Treating with nucleases to remove residual nucleic acids and 
then rinsing with serum-free basal medium and stored at 4° C. The liver’s 
collagen types include types I, III, IV, V, VI, and XVIII. 
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Figure 18. Data illustrating the stability of the normalized perfusion area (NPA) and normalized perfusion speed (NPS) before and 
after modifying the contrast injection protocol. Images A and B represent data before syringe mixing, while C and D show after 
syringe mixing. Note the improvement in consistency (i.e. the reduction in percent standard deviation) for both parameters after 
implementing syringe mixing.  
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Figure 19. The matrix scaffold was housed in a bioreactor containing 200 ml of medium.  A) The hepatoblast-like cells, Hep3bs, were 
introduced into the matrix scaffold by perfusion through the portal vein via a peristaltic pump. B) Photograph of a reseeded matrix 
scaffold housed in the bioreactor.  
 
 
64 
  65
 
 
 
CHAPTER IV 
 
Motivation for Organoid Studies 
 
The biomatrix scaffolds are improving the culture of cells by supporting their 
differentiated functions of cells more than any known matrix extract. However, they are not 
readily converted to industrial scale usage. Wang et al. pulverized the biomatrix scaffolds and 
the powder was allowed to sediment onto culture dishes (8). The dishes coated with biomatrix 
scaffold powder did indeed support rapid attachment and differentiation, but the extent of 
differentiation was significantly lower than when frozen sections were used (8) or when the 
scaffolds were used intact (Arial Hanson et al, manuscript in preparation). We hypothesized that 
the pulverization process resulted in many of the matrix components, especially the 
proteoglycans, became vulnerable to solubilization in media. The primary objective of this thesis 
was to identify methods that would most optimally use the biomatrix scaffold extracts to 
preserve the critical components of the matrix but in a way that was scalable for use in industry.  
The current status of drug testing in the industry is an area that has potential for 
substantial improvement. Many of the drugs in development fail and do not pass the stringent 
regulations set by the Food and Drug Administration (FDA). These drugs candidates have been 
selected from thousands of others and are required to be investigated by numerous preclinical 
studies. Success in these studies will allow the drug candidates to proceed to clinical trials. 
Unfortunately, more than half of these drug candidates fail. At this point, a significant amount of 
time and capital has already been invested into these drug candidates, and these failures in 
clinical trials are a source of major losses in finances and resources within the industry. A widely 
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recognized solution is the identification and elimination of drugs early on in the development 
process. There is a demand for a method(s) that not only accurately models the drug biology in 
humans but is also cost effective with scalability. Many recent studies have focused on 
mimicking the native biology as closely as possible but disregard the importance of scalability to 
the feasibility of successfully implementing these methods in the industry. Biomatrix scaffolds 
are constrained by the size of the native organ and limit culture availability. A method that can 
be scaled would enable a more cost effective high-throughput preclinical screening of drugs and 
allow a more thorough assessment of the potential for a drug to succeed in clinical trials. This 
would help in eliminating more candidates early on in the process and help minimize the loss of 
resources.
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CHAPTER V 
 
Stem-cell derived, Functional Human Hepatic Organoids  
in Hyaluronan Hydrogels containing Pulverized Liver Biomatrix Scaffolds1  
 
Synopsis 
The success of ex vivo models for industrial applications is closely linked to their ability 
to mimic physiological/biological processes. We have established functional human hepatic 
organoids by culturing human hepatic stem cells (hHpSCs) in a serum-free, hormonally defined 
medium (HDM) and in hyaluronan hydrogels containing pulverized biomatrix scaffolds obtained 
from decellularization of liver tissue. The decellularization process results in extracts containing 
~99% of the liver’s collagens (cross-linked, non-cross-linked and nascent ones), essentially all 
known collagen-associated matrix components, and physiological levels of matrix-bound growth 
factors and cytokines. Within a few days in the hydrogel and decellularized matrix mixture, 
hHpSCs differentiated to have a gene expression profile similar to that of mature hepatocytes 
and with secreted proteins associated with hepatic metabolism. The effects proved 
concentration dependent for the biomatrix scaffold components. This method has the potential 
for industrial scalability and thus has implications for therapeutic and industrial applications. 
 
1This chapter features a manuscript in preparation at the time this thesis was published: 
Bryant Wu, Eliane Wauthier, Ariel Hanson, Mitsuo Yamauchi, and Lola M. Reid. Stem-cell 
derived, Functional Human Hepatic Organoids in Hyaluronan Hydrogels containing Pulverized 
Liver Biomatrix Scaffolds. Manuscript in preparation.  
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Introduction 
Ex vivo models of human livers are highly desired by investigators in academia and 
industry especially given the difficulties in obtaining high quality human livers for the purpose of 
research. Efforts to establish such models have been ongoing for more than 50 years with 
varying degrees of success (189, 190). Requirements for the most successful versions of such 
models include a need for 3-dimensionality (3D) and a mixture of the epithelial and 
mesenchymal cells such as that which occurs in organoids (6, 46, 64, 191). Also required are a) 
serum-free media with wholly defined hormonal and nutritional constituents (11), b) co-cultures 
with tissue-specific and lineage specific mesenchymal cell partners that confer essential 
paracrine signaling (76, 192), and c) complex mixtures of extracellular matrix components (7, 8, 
128). In addition, the limitation in available, freshly isolated human liver cells coupled with their 
limits in proliferation have caused investigators to pursue various forms of stem cell populations 
that can self-replicate extensively and then can be lineage restricted to an adult hepatic fate.  
Decellularization of organs to yield tissue-specific extracts enriched in the complex 
mixture of extracellular matrix components that can support differentiation has been known for 
over 30 years (147, 148). Renewed interest in these strategies has occurred in recent years and 
has resulted in the generation of scaffolds being tested for their efficacy in differentiating cells ex 
vivo and even in vivo (7, 8, 130). Although studies are ongoing that analyze matrix scaffolds of 
many tissue types, the most extensively characterized ones have focused on liver. In all those 
studied, the scaffolds have been prepared for use in monolayer cultures (8) or as intact 
scaffolds(7, 132) – forms that limit scalability for industrial use.  
Hepatic organoids are aggregates of hepatic parenchymal cells that include hepatocytes 
and cholangiocytes, along with their partner mesenchymal cells that include endothelia and 
hepatic stellate cells. When the cells are kept in suspension under appropriate conditions, they 
aggregate into subunits mimicking their cellular relationships in vivo. They can last in culture for 
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weeks to months and yield the best functionality of parenchymal cells maintained ex vivo (19). 
Their ability to be industrially scaled is limited by the lack of vascularization. 
Each organoid typically consists of around 10,000 hepatocytes and is limited in the 
numbers sustainable per culture volume and thus limited in scalability. Moreover, there is limited 
proliferation of adult cells when triggered to generate organoids, meaning that one has to 
prepare them with freshly isolated cells.   
Here we show that one can achieve scalability of organoid cultures by taking advantage 
of the proliferative capacity of hepatic stem cells, maintained under self-replicative conditions, 
and then use the stem cells to generate large numbers of functional hepatic organoids by 
subjecting them to differentiation conditions. Identification and isolation of human hepatic stem 
cells (or biliary tree stem cells) from human livers of all donor ages were demonstrated 
previously (65, 69). The hepatic stem cells and subpopulations of biliary tree stem cells (178) 
are able to be expanded ex vivo on culture plastic or on hyaluronan substrata and in serum-free 
Kubota’s Medium (KM) designed for culture selection and maintenance of endodermal 
stem/progenitor cells (76, 177).  
 The colonies of hepatic (or biliary tree) stem cells can be transferred to differentiation 
conditions that lineage restrict them to adult parenchymal cell fates by conditions comprised of a 
serum-free hormonally defined medium (HDM) and substrata of biomatrix scaffolds (8), 
designed to differentiate the cells to adult liver. Here we adapt this strategy to one that is 
scalable by using the HDM in combination with embedding the stem cells into hyaluronan 
hydrogels containing pulverized liver biomatrix scaffolds, a potent mixture of signals and factors 
that drive the stem cells to hepatic organoids within 5 days.   
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Materials and Methods  
Companies 
The companies from which tissues or reagents were obtained include: Advanced 
Biological Resources (Alameda, CA): ALPCO Diagnostics (Salem, NH); Applied Biosystems 
(Grand Island, NY); Becton Dickenson (Franklin Lakes, NJ); Bethyl Laboratories (Montgomery, 
TX); Biotime (Alameda, CA); Cedarlane Labs (Burlington, NC); Charles River Laboratories Int’l 
(Wilmington, MA); Clontech Laboratories (Mountain View, CA); Gibco (Grand Island, NY); 
Invitrogen (Grand Island, NY); Molecular Devices (Sunnyvale, CA); Olympus (Melville, NY); 
PhoenixSongs Biologicals (Branford, CT); RayBiotech, Inc (Norcross, Georgia); Sigma (St. 
Louis, MO); Spex SamplePrep (Metuchen, NJ); Thermo Fisher Scientific (Waltham, MA); 
Triangle Research Laboratories (RTP, NC).  
 
Animals 
Sprague Dawley Rats were obtained through Charles River Laboratories International. 
The liver biomatrix scaffold isolation protocol was reviewed and approved by the Institutional 
Animal Care and Use Committee (IACUC) at the University of North Carolina at Chapel Hill. 
 
Media and solutions 
All media were sterile-filtered (0.22-μm filter) and kept in the dark at 4°C before use. To 
keep collagens stable in the biomatrix scaffolds during decellurization, the pH of the perfusion 
media was kept at 7.5-8.0. DMEM/F:12 (Gibco) was used as the basal medium for preparation 
of biomatrix scaffolds. RPMI-1640 (Gibco) was used for cultures of hepatocytes or HpSCs.  
 
Kubota’s medium 
KM consists of any basal medium, here being RPMI 1640 (Gibco), supplemented with 
0.1% BSA (fatty acid-free bovine serum albumin, Fraction V; Sigma) and niacinamide (Sigma), 
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with no copper, 0.3 mM calcium concentration, supplemented with trace elements – zinc (10-
12M), selenium (10-9M), insulin and iron-saturated transferrin (both at 5 µg/ml; Sigma-Aldrich), 
hydrocortisone (10-7M), a mixture of free fatty acids bound to bovine serum albumin, L-
Glutamine (200 mM), and antibiotics (AAS; Invitrogen). Detailed methods for its preparation are 
given in a published review (11).  
 
Hormonally defined Medium for Differentiation of Cells to Adult Liver Cells (HDM-L) 
The HDM-L was prepared by supplementing KM with calcium to achieve 0.6 mM 
concentration, 1nM tri-iodothyronine (T3), 7 ng/ml glucagon, 10-12M copper, and 2 g/L 
galactose. Classic factors needed for mature hepatocyte differentiation were also added 
including epidermal growth factor (EGF, 20 ng/ml), basic fibroblast growth factor (bFGF, 10 
ng/ml), hepatocyte growth factor (HGF, 10 ng/ml), and Oncostatin M (10 ng/ml) (76). Detailed 
methods for its preparation are again given in the published methods review (11). 
 
Human fetal liver processing 
Fetal liver tissues were provided by an accredited agency (Advanced Biological 
Resources) from fetuses between 16-20 weeks gestational age obtained by elective pregnancy 
terminations. The research protocol was reviewed and approved by the Institutional Review 
Board for Human Research Studies at the University of North Carolina at Chapel Hill. 
Suspensions of fetal human liver cells were prepared as described previously (65, 76). All 
processing and cell enrichment procedures were conducted in Kubota’s Medium. Liver tissue 
was subdivided into 3-ml fragments (total volume ranged from 2-12 ml) for digestion in 25 ml of 
cell wash buffer containing type IV collagenase and deoxyribonuclease (both at 6 mg/ml; 
Sigma) at 32°C with frequent agitation for 15-20 min. This resulted in a homogeneous 
suspension of cell aggregates that were passed through a 40-gauge mesh and spun at 1,200 
RPM for 5 min before resuspension in cell wash solution. Erythrocytes were eliminated usually 
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by slow-speed centrifugation (76). They were eliminated in a few studies by treating 
suspensions with anti-human red blood cell antibodies (1:5,000 dilution; Rockland) for 15 min, 
followed by LowTox Guinea Pig complement (1:3,000 dilution; Cedarlane Labs) for 10 min, both 
at 37 ° C; this was not done routinely, since there was some loss of the stem cell 
subpopulations. Estimated cell viability by Trypan blue exclusion was routinely >95%. 
 
Culture selection for Hepatoblasts (HBs) versus Hepatic Stem Cells (HpSCs) 
Freshly processed human fetal liver cell suspensions are comprised mostly of 
hepatoblasts (hHBs; 80-85%), a small percentage of hepatic stem cells (hHpSCs; ~0.5-2%), 
and the remainder are hematopoietic cells (~14%) and various mesenchymal cells (3-5%). Of 
the parenchymal cell fraction the hHBs are ~98% and the hHpSCs are ~1-2%. All were plated 
onto culture plastic and in serum-free Kubota’s Medium (KM) and placed in an incubator at 5% 
CO2/air mix and 37°C. Immediately after plating, and for up to 5 days, the cultures were 
comprised primarily of the larger (12-15 µm) hHBs. After 5 days, the hHBs and all other cell 
types die under these conditions, except for the smaller (7-9 µm) hHpSCs. Bound to the hepatic 
stem cells are their mesenchymal partners, angioblasts. These hHpSCs and their angioblast 
partners survive indefinitely in these conditions and are culture selected within ~one week; that 
is all other cell types and lineage stages of cells die. Colonies of the hHpSCs reach a size of 
~2000 cells/colony within 10-14 days.    
The plating conditions consisted of the cell suspension seeded at ~300,000 cells per 100 
mm2 round culture dish (78.5 cm2 surface area). Cells were plated with 5% fetal bovine serum 
(FBS) for 20-24 hrs (ideally for only ~6 hrs) to facilitate attachment. Afterwards cell media were 
changed every 4-6 days with serum-free KM. The low seeding numbers resulted in sparse 
plating that is optimized for culture selection of the hHpSCs, and that in combination with the 
absence of serum (except for the initial plating) minimized the conditions for any mature 
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hepatocytes or for the non-parenchymal cells (with any serum supplementation, the 
mesenchymal cells rapidly take over the cultures).  
The typical plates had single cells and small cell clusters that adhered after the initial 24 
hrs. Colonies formed within 5-7 days and were observed for up to 3 months by which time each 
colony contained approximately 2,000-5,000 cells per colony. Non-parenchymal cells, found to 
be a mix of precursors for hepatic stellate cells and endothelial cells, also continued to grow on 
the plates, typically around the perimeters of the colonies; the colonies grew forming a smooth 
supporting edge or sometimes formed large, confluent tightly bound cells.  
The hHpSC colonies were isolated after 14-18 days by using a pipette tip to pick the 
colonies by hand using an inverted microscope (1X-FLAIII; Olympus). The colonies were 
attached primarily at their perimeters, whereas the centers of the colonies were not attached, 
making recovery by this manual method logical. The colonies were then suspended in serum-
free KM. The average number of cells/colony was ~2500 cells. The hHpSC colonies were 
allowed to settle to the bottom of  microcentrifuge tubes for collection (Figure 4).  
 
Human adult liver cell isolation and culture 
Fresh human hepatocyte cell suspensions were obtained from Triangle Research 
Laboratories (RTP, NC), and then either were processed immediately for RNA/DNA quantitative 
analysis or seeded into pulverized biomatrix-hyaluronan cultures with a serum-free, hormonally 
defined medium (HDM) tailored for maintenance of adult hepatocytes (PhoenixSongs 
Biologicals; Catalog # MM250) at cell densities recommended by TRL.   
 
Quantitative Analyses of DNA and RNA Content 
To assess total DNA remaining in the decellularized livers, fresh rat liver tissue and liver 
biomatrix scaffolds were weighed, cut and digested with Proteinase K and total cellular DNA 
was isolated following published protocols (193). To assess total RNA remaining in the liver 
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biomatrix scaffolds, both fresh rat liver tissue and rat liver biomatrix scaffolds were weighed and 
homogenized in TRIzol solution (Invitrogen), and total cellular RNA was isolated following 
manufacturer’s instructions. 
 
Collagen and adhesion molecule chemistry analysis 
The amount of collagen in the biomatrix scaffolds was evaluated based on the 
hydroxyproline (hyp) content. Samples of whole livers (n=4) and of biomatrix scaffolds (n=6) 
were pulverized, washed and lyophilized. Aliquots were then hydrolyzed and subjected to amino 
acid analysis (194), and the collagen content per total protein was estimated based on the hyp 
value of 300 residues/collagen. Assays were measured individually with a cytofluor Spectramax 
250 multi-well plate reader (Molecular Devices). 
Growth factor assays 
Samples of rat livers and rat liver biomatrix scaffolds were subjected to analyses for 
growth factors. The samples were flash-frozen in liquid nitrogen, pulverized into a powder, and 
sent in for analysis to RayBiotech, Inc. (Norcross, GA). These were then assayed with 1 mg/ml 
protein, yielding fluorescence, defined in fluorescent intensity units (FIUs). Semi-quantitative 
growth factor assays were done using the RayBio® Human Growth Factor Arrays, G Series 1. 
The FIUs were reduced by that for negative controls for non-specific binding and normalized to 
protein concentration. The data from the duplicates were averaged. Forty growth factors were 
assayed on fresh, rat liver tissue (n=3) and compared to assays from biomatrix liver scaffolds 
(n=3). Although the assays were developed for human growth factors, there is sufficient overlap 
in cross-reaction to rat growth factors to permit use for both the rat and human samples. 
 
Quantitative Real Time PCR (qRT-PCR) analyses 
Total RNA from monolayer cultures (positive control cells: hHpSC colonies) and freshly 
isolated hHBs were extracted with the RNeasy Mini Plus kit (QIAGEN) and by using TRI 
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Reagent (Invitrogen). Total RNA from the biomatrix/hyaluronan cultures was extracted using the 
TRI Reagent (Invitrogen). The cDNA was generated using the Takara Prime Script First Strand 
cDNA Synthesis Kit (Clontech Laboratories). Gene-specific primers (Supplemental Table 1) 
were validated using cDNA templates generated from relevant cell lines expressing each gene 
of interest. Gene expression baselines were defined using cDNA templates generated from 
hHBs and monolayer cultures (2D) of hHpSC colonies obtained from 3 different fetal livers. The 
hHBs were isolated from initial fetal liver preparations and constituted 98% of the parenchymal 
cell fraction (11, 65). The hHpSCs were derived from culture-selected colonies from plating of 
the fetal liver cell suspension in KM. Gene expression levels of hHpSCs in HA hydrogels were 
measured for 8 different biomatrix scaffold concentrations (2 samples per formulation, ~0.25 ml 
sample volume, seeding density: 50-100 colonies/sample) with hHpSC colonies obtained from 
the same fetal liver source; incubated in parallel with medium changes of KM every other day; 
collected after 5-7 days of culture; and fully repeated for 2 different fetal livers. Quantitative Real 
Time PCR (qRT-PCR) measurements were performed with an Applied Biosystems® 7500 Real-
Time PCR System available in the Functional Genomics Core Facility at UNC Chapel Hill for the 
following genes: EpCAM, CXCR4, CK7, CK19, AFP, Albumin, Transferrin, TAT, and G6PC 
(Supplemental Table 1). All measurements of relative expression were normalized with respect 
to GAPDH by the absolute quantification method described elsewhere (195, 196). 
 
Analyses of secreted protein production 
Concentration levels of secreted AFP and albumin in culture media were measured to 
determine hepatic functions of hHpSCs in biomatrix/hyaluronan hydrogels with different 
biomatrix concentrations throughout 5-7 days of culture. Media supernatants were collected 
every other day from cultures of cells in 8 different biomatrix scaffold concentrations (2 samples 
per formulation, ~0.25 ml sample volume) starting 24 hours post-seeding and stored frozen at -
20°C until analyzed. Secretion of AFP was measured by enzyme-linked immunosorbent assays 
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(ELISA) using human AFP ELISA kits (ALPCO Diagnostics). Albumin production was measured 
by ELISA using human albumin ELISA quantitation sets (Bethyl Laboratories). All assays were 
measured with a Cytofluor Spectramax 250 multi-well plate reader (Molecular Devices). 
 
Statistical analysis 
Experiments were repeated at least 2-3 times with duplicate or triplicate samples for 
each condition. Data from representative experiments are presented; similar trends were seen 
in multiple trials. Experimental quantitative data are displayed in a mean ± 1 standard deviation 
format in charts or displayed in a mean ± 1 standard error format in plots (as indicated). 
Significance of gene expression levels with respect to both hHpSCs (p-value: * < 0.05, ** < 0.01, 
*** < 0.001) was determined by two-tailed Student’s t-test. All individual sample measurements 
were performed at least in duplicate. 
 
Results 
Liver Biomatrix Scaffold Preparation 
Rat liver biomatrix scaffolds were prepared by decellurizating the livers from Sprague 
Dawley rats. Prior to surgery, the rats were anesthetized with 100 mg/kg of Ketamine and 10 
mg/kg of Xylazine. After becoming unconscious from the anesthetic, the rat’s abdomen was 
exposed by making an incision from the pelvis to the sternum. The sternum was cut and 
removed while avoiding the diaphragm and rib cage, prolonging the beating of the heart in order 
to maintain blood flow through the liver. A catheter was used to cannulate the portal vein, and 
blood in the liver was removed via perfusion with DMEM/F:12 for 30-40 minutes. After the blood 
was removed, the liver was perfused with a phosphate buffered saline (PBS) solution containing 
1% (w/v) sodium deoxycholate (Sigma), 0.1mg/mL CaCl2 (Fisher), and 36 units/L of 
Phopholipase A2 (Sigma) for 50 minutes until the tissue became transparent. These conditions 
rapidly degrade the enzymes produced by the disrupted cells during delipidation and so the 
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conditions preserve the native liver matrix components (e.g. adhesion molecules, 
proteoglycans, and glycosaminoglycans). Subsequently, the liver was perfused for 100 minutes 
with a buffer containing 3.4 M NaCl and supplemented with soybean trypsin inhibitor (Sigma); it 
was then rinsed by perfusion with DMEM/F:12 for 30 minutes. The buffer conditions are at salt 
concentrations that keep all of the collagens in the liver insoluble, whereas other cellular 
components that are not collagen-bound are solubilized and can be eliminated. The initial rinse 
was comprised of trypsin inhibitor (Sigma), DNase (Sigma) and RNase (Sigma) for 15 minutes; 
and finally rinsed by perfusion with DMEM/F:12 for another 30-60 minutes (Figure 1). The liver 
was then removed and cut into small pieces to be flashed frozen by submerging the pieces in 
liquid nitrogen for a few minutes. In order to facilitate pulverization, the small pieces were then 
broken into even smaller pieces with a disinfected pulverizing tool. These were stored at -80°C 
until the day of pulverization (Figure 1). 
 
Characterization of Rat Liver Biomatrix Scaffolds 
Freshly isolated rodent livers were obtained from healthy rats weighing 250-300 g. Liver 
decellularization was achieved as described above. After decellularization, the liver biomatrix 
scaffolds had a whitish, opaque appearance with visible branching of the vasculature throughout 
the acellular scaffold. The decellularized liver tissue was slightly larger in size when compared 
to that of the native liver but retained its liver shape and macroscopic appearance (Figure 1). 
To estimate the efficiency of the decellularization and examine characteristics that might 
affect hepatic differentiation, samples of the liver biomatrix scaffolds were subjected to a variety 
of assays and compared to native livers as controls. The amount of nucleic acids remaining in 
the biomatrix scaffolds after decellularization was measured and determined to be insignificant 
when compared to the nucleic acid content found in fresh liver tissue, confirming the efficiency 
of the decellularization process.  
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Collagen is a primary component of the extracellular matrix to which many other factors 
(e.g. glycoproteins and proteoglycans) are attached and is comprised of cross-linked collagens 
and nascent collagens that are not cross-linked. The collagen content was analyzed and 
quantified by methods utilizing the fact that hydroxyproline (Hyp) is a unique component of 
collagens and collagenous proteins. The results were estimated based on the Hyp value of 300 
residues/collagen and demonstrates that the decellularization process results in biomatrix 
scaffolds that retain ~99% of the collagens found in the native liver (Figure 2). Additional matrix 
components found to be present included fibronectins, laminins, and elastin among others (8). 
Proteoglycans and their glycosaminoglycan (GAG) chains are the primary chemical scaffolds for 
bound growth factors and cytokines (82). Growth factor analysis determined that most of these 
growth factor and cytokine components were preserved and were found at levels comparable to 
those in samples of fresh liver tissue (Figure 2). With a few exceptions, there was an equally 
proportional decrease in FIUs across over forty growth factors indicating uniformity in the 
decellularization process. 
 
Pulverization of Biomatrix Scaffolds 
Pulverization at liquid nitrogen temperatures was used as a method to generate powders 
of biomatrix scaffolds that might be used as an industrially scalable product. Prior to 
pulverization, the grinding vials, caps, and magnets (Spex Sample Prep) were disinfected in 
10% bleach for 30 minutes, 1% bleach for an hour, and sterile water overnight. The following 
procedure was performed on dry ice (Figure 1). Specific quantities of flash frozen biomatrix 
scaffolds were aliquoted to attain specific concentrations when re-suspending the pulverized 
biomatrix powder with medium in preparation for cell culture. The disinfected grinding vials were 
capped on one side with a magnet inside. The measured quantities of frozen biomatrix scaffolds 
were carefully placed into the grinding vial with the magnet already inside while leaving some 
space near the top for the magnet to move initially in the pulverization cycle and for the grinding 
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vial to be capped. The vial was transferred and positioned within a Freezer/Mill 
(SpexSamplePrep). With safety gloves and apparel in place, liquid nitrogen was poured into the 
open Freezer/Mill (Spex SamplePrep) until nearly full. The placement of the grinding vial was in 
the pulverization slot of the top part of the machine and two others were placed in the incubating 
area right above (Figure 3). The top was then slowly lowered into the bottom of the Freezer/Mill 
to avoid liquid nitrogen overflow. The three samples were allowed to sit for 5 minutes to reach 
liquid nitrogen temperature before the machine was started. The Freezer/Mill was run for 5 
minutes at a grinding rate of 14 impacts/second/side. When completed, the machine was 
opened and the vial from the pulverization slot was removed and placed at room temperature. 
One of the vials in the incubation slot was moved to the pulverization slot and replaced with 
another prefilled grinding vial and the machine was run again after the machine was refilled with 
liquid nitrogen. This cycle was repeated until all the samples in the grinding vials had been 
pulverized. Unless the grinding vials are compatible with the vial opener, the pulverized vials 
were allowed to sit at room temperature for at least 5 minutes for safety reasons before 
attempting to remove the caps by hand. While the powder was still frozen inside, the grinding 
vial was disinfected and the cap was removed with a back and forth wobble movement in the 
hood. The powder was then removed with a cold spatula that had been stored in dry ice, placed 
into a cold 50 mL conical tube, and stored at -80°C until thawed for cell culture (Figure 3). 
 
Hyaluronan Hydrogel Cultures containing Pulverized Liver Biomatrix Scaffolds 
Since the pulverized liver biomatrix powder is suspended in a solution or medium when 
thawed, many of the components can be lost during media changes when used in cell culture. 
To prevent this, hyaluronans, found naturally in all tissues, were utilized as a gelation factor to 
retain as many of the matrix components as possible. The hyaluronans, even prior to gelation, 
form a somewhat viscous solution into which cells can be suspended. Biomatrix-hyaluronan 
mixtures were prepared with final concentrations of 20 mg/mL of hyaluronic acid sodium salt 
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from Streptococcus equi (Sigma) and from 10 to 150 mg/mL of the pulverized liver biomatrix 
scaffolds.  
To prepare the materials used in cultures of the hHpSCs, 0.02 g of hyaluronan powder 
was weighed, and the weigh paper was folded to form an enclosed container for each pair of 
cultures to keep the powder in a sterile environment (Figure 3). Also, 1 mL oral syringes 
(Becton Dickenson) were placed in sealed plastic bags. Finally, the 50 mL conical tube 
containing the stocks of pulverized biomatrix scaffolds was placed on dry ice, and enough 
powder was removed for the cultures planned. This powder was placed into a 15 mL conical 
tube and allowed to thaw into a liquid. The culture materials, including the hyaluronan 
containers and the oral syringes, were irradiated for 5 minutes in a Gammacell 1000 ELITE 
Irradiator for a total of 3250 rads, while the thawed pulverized biomatrix scaffolds were 
irradiated for 10 minutes for a total of 6500 rads to ensure sterility. 
During the following steps, the materials were kept sterile under the hood and the 
solutions were kept well mixed either by shaking or vortexing before each step. For each 
duplicate of pulverized liver biomatrix scaffolds and hyaluronan (pLBM-HA) culture, 1 mL of 
Kubota’s Medium was aliquoted into a 5 mL Round Bottom Test Tube (BD). To each test tube, 
specific volumes of thawed pulverized biomatrix were added and then vortexed to attain desired 
concentrations (Figure 3). For each test tube, the weigh paper containing the pre-weighed 
hyaluronan powder was removed from the plastic bag and slowly unfolded. The powder was 
carefully added to the 5 mL round bottom tube while minimizing contact of the powder with the 
sides of the test tube (Figure 4). The tubes were capped, and the mixture was immediately 
shaken vigorously in an up and down motion until the hyaluronan powder was fully dissolved in 
the biomatrix scaffold/media mixture. Then, with one last whipping motion, the entire mixture 
was forced to the bottom of the tube. A 1 mL oral syringe was then carefully removed from the 
plastic bag and used to gather and slowly aspirate the pLBM-HA mixture into the syringe with an 
average yield of 0.5 mL (Figure 4). Equal volumes of the aspirated mixture were added to one 
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of two wells in a 24-well plate. This was repeated for each mixture of pLBM-HA cultures. After 
allowing the material to incubate and settle into an even surface in the wells of the 24-well plate 
for ~20 minutes, the pLBM-HA mixture had an opaque appearance with some visible white 
streaks throughout the mixture that resembled webbing (Figure 4).  
Each culture was then seeded with 50-100 hHpSC colonies. The colonies were allowed 
to equilibrate into this viscous material for 2-3 hours and then 1 mL of Kubota’s Medium was 
very slowly added drop-wise to each well to try to avoid disturbing the pLBM-HA culture (Figure 
4). After 24 hours, the medium was then slowly aspirated and replaced in the same drop-wise 
fashion with either Kubota’s Medium or with a Hormonally defined Medium for Liver (HDM-L).  
Media changes were done every other day for 5-7 days. The collected medium was stored at -
20°C for further analysis. Additional colonies of hHpSCs were picked on the day the cultures 
were seeded to serve as controls. 
 
Characterization of hHpSCs in pLBM-HA cultures 
Two weeks after the liver cell suspensions were plated onto plastic, hHpSC colonies 
began to appear and had a round appearance with clear borders. However, after isolating and 
seeding them into the pLBM-HA cultures, these hHpSC colonies formed 3D structures that 
transitioned into hepatic organoids. After a day of equilibrating in the pLBM-HA culture 
conditions, the hHpSC colonies lacked a distinct border and had an appearance of aggregates 
of cell clusters (Figure 5a,5c,5e). These cell clusters were visible throughout the colony and 
were slightly pigmented in appearance; the significance of the pigmentation is assumed related 
to differentiation but is not yet fully understood.  After five days of culture, the hHpSC colonies 
retained a clear border once again by forming hepatic organoids with a much darker coloration 
as compared to the original slightly pigmented appearance (Figure 5b,5d,5f). In some cases, 
hHpSC colonies could be seen forming attachments to the bottom of the well (Figure 5d). Also, 
the pulverized biomatrix scaffold material was visible in culture and disappeared around the 
  82
colonies after 5 days of culture particularly in samples with higher concentrations of biomatrix 
scaffold material. 
 
Functional assays of hepatic metabolism for hHpSCs cultured in pLBM-HA.    
Immunosorbent assays were conducted on media samples collected every other day 
throughout the 5-7 days in culture to measure concentrations of secretory proteins indicative of 
hepatic functions and were compared between cultures with varying concentrations of 
pulverized liver biomatrix scaffolds (Figure 6). Measurements for each sample were calculated 
by normalizing to the respective amount of target initially secreted after 1 day of equilibration 
and calculating the fold change in order to account for variability in cell number between 
samples. Sample concentrations are represented to be compared over time (Figure 6a,6b) and 
between concentrations (Figure 6c,6d). Throughout the 7 days in culture, the hHpSCs secreted 
both AFP and Albumin at increasing concentrations into the medium with concentrations 
peaking on day 5 and decreasing minimally on day 7 (Figure 6).  AFP and Albumin secretion 
rates always increased in each respective sample with the greatest change at the pulverized 
liver biomatrix concentration of 100 mg/ml (Figure 6). Secretion rates for both AFP and 
Albumin/day of media samples displayed a positive correlation with respect to pulverized liver 
biomatrix concentration with 0 mg/ml having the smallest change and 100 mg/ml having the 
greatest change (Figure 6). 
 
Gene expression in hHpSCs cultured in pLBM-HA 
The hHpSC colonies cultured in pLBM-HA were analyzed for mRNA expression of 
specific genes. Measurements of mRNA expression of hHpSCs isolated from fetal livers (n=3) 
were normalized to GAPDH expression (Figure 7-9). All measurements are expressed as fold 
changes normalized to the mRNA expression levels of hHpSC colonies isolated the same day 
but not seeded into the pLBM-HA environment. 
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 After being cultured for 5 days in the pLBM-HA mixture, the cells in the hHpSC colonies 
developed phenotypic traits of an intermediate transitional stage between that of hepatoblasts 
(hHBs) and mature hepatocytes (Figure 7,9). This can be seen in the increased expression 
levels of AFP and Albumin along with the increased expression levels of an array of genes 
commonly found in the expression profile of mature hepatocytes (e.g. glucose-6-phophatase, 
tyrosine aminotransferase, transferrin). When comparing the freshly isolated hHpSC colonies to 
the hHpSC colonies cultured in the pLBM-HA mixture for 5 days, the differences were significant 
in the mRNA expression of genes commonly expressed by hHBs and mature hepatocytes 
(Figure 7,9). Despite the similarities in their mRNA expression profiles, the expression levels of 
these genes in the hHpSC colonies cultured in pLBM-HA were much lower and achieved 
around 20% of the levels expressed by mature hepatocytes after 5 days of culture 
(Supplemental Figure 1) and around 10% of the levels after 7 days of culture (Supplemental 
Figure 2). Furthermore, the expression levels of certain genes in the hHpSC colonies cultured 
in the pLBM-HA mixture for 5 days were surprisingly similar to that of the freshly isolated hHpSC 
colonies (Supplemental Figure 3). This could indicate that some of the cells in the hHpSC 
colonies cultured in the pLBM-HA mixtures retained some properties of the cells in the hHpSC 
colonies when they were freshly isolated.  
 In addition to the differences between hHpSC colonies cultured in the pLBM-HA mixture 
and the freshly isolated hHpSC colonies, expression levels also varied between hHpSC 
colonies cultured in various concentrations of pulverized liver biomatrix when comparing the 
mRNA expression profiles of genes commonly expressed by hHBs and mature hepatocytes. 
After 5 days of culture in the pLBM-HA mixture, the hHpSC colonies cultured at the various 
concentrations of pulverized liver biomatrix scaffolds displayed a positive correlation in mRNA 
expression with 0 mg/ml having the lowest expression levels and 100 mg/ml having the highest 
expression levels with a few exceptions (Figure 7,9). Despite this trend in increased expression 
as the concentration of pulverized biomatrix increases, many of the differences between the 
  84
expression levels could not be characterized as significant (Figure 7). However, on day 7, 
hHpSC colonies cultured at the concentration of 100 mg/ml of pulverized liver biomatrix had an 
expression profile that was significantly different from the expression profile of the hHpSC 
colonies cultured at the concentration of 0 mg/ml of pulverized liver biomatrix scaffolds with the 
hHpSC colonies at the concentration of 100 mg/ml having much higher mRNA expression levels 
of genes commonly expressed by hHBs and mature hepatocytes (Figure 8).  
 
Discussion 
We have developed a strategy by which to establish functional human hepatic organoids 
derived from hepatic stem cells by culturing them with serum-free HDM-L, designed for mature 
liver cells, and in hyaluronan hydrogels into which are mixed pulverized liver biomatrix scaffolds. 
The design is permissive for industrial scalability.    
The need for complex forms of extracellular matrix has been made apparent by decades 
of studies, especially ones within recent years (96, 122-127, 129, 147, 197). The old methods of 
plating cells onto simple collagens or even in collagen sandwiches enabled cells to have many 
more adult functions than in cells cultured on plastic but the effects proved transient and only 
partially effective (20, 21, 26-28). Better results to date have been made possible with the use of 
matrix extracts prepared by decellularization of tissues with methods ranging from freezing and 
enzymatic protocols (174) to delipidation followed by distilled water washes (7, 132). 
However, the potency of matrix scaffolds has been minimized by the methods by which 
the scaffolds have been prepared, methods that cause major losses in matrix components. With 
the protocols of others, the loss of matrix components occurs at every step, even the first step 
(delipidation). Most decellularization methods use detergents to delipidate the cells, and the 
delipidation strategies usually make use of harsh solutions such as Triton X-100, sodium 
dodecyl sulfate (SDS), and CHAPS, (7, 130, 132). SDS binds tightly to the matrix making it 
toxic, and requires long washes to minimize that toxicity (140). In addition, these detergents 
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disrupt the native architecture of the matrix and enhance its solubility (28). A gentler alternative 
was used in our experiments and involved bile salts. particularly sodium deoxycholate (SDC) 
used in conjunction with the enzyme Phospholipase A2 (PLA2). This method quickly (within 20 
minutes) delipidates the tissue. Specifically, PLA2 is activated by SDC and degrades the 
phosphoglyceride on both the cytoplasmic and mitochondrial membranes into a surfactant 
called lysolecithin, which causes rapid cell necrosis (8).  
Secondary to delipidation, the decellurization protocols by others use freezing or even 
some matrix-degrading enzymes (174) and then all make use of washes that are with low ionic 
strength buffers and even distilled water. The combination of these steps, especially after the 
delipidation steps, results in the dissolution of most of the matrix components except for the 
cross-linked collagens and their associated factors (198).   
All efforts yield scaffolds with some biological activity, certainly much more than the use 
of purified, single matrix components (199, 200). However, all methods with the exception of the 
one reported here cause such a loss of matrix components that compensatory efforts are 
required to restore cell attachment or to overcome loss of patency with the matrix remnants of 
the vascular channels. In addition, the cells must be cultured for long periods of time (often 
weeks) to allow functionality of the cells to be restored (7, 131-134). Though these 
compensatory efforts help, they do not restore the histologically accurate location of the matrix 
components. The more successful compensatory methods have been the transplantation of 
scaffolds seeded with cells in order to let restoration occur in vivo (129, 130, 197) 
Our protocol contrasts sharply with those of others in that it retains far more of the matrix 
chemistry and maintenance of histologically accurate positioning of the matrix components (8, 
201). The experimental design that allowed this is derived from a focus on the collagens, which 
are the central scaffolds of the matrix.  By retaining as much and as many of the collagens as 
possible, including cross-linked, non-crosslinked and nascent forms, we theorized we would 
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retain more of the extracellular matrix. We made use of the methods of Edward Miller (145, 146, 
202) who used buffers at salt solubility constants known to keep the collagens insoluble.  
We determined the collagen types in liver (e.g. types I, III, IV, V, VI) and then utilized 
buffers with a salt concentration requisite to keep these collagens insoluble (8, 147). This 
enabled preservation of essentially all of the collagens (~98-99%) including both nascent and 
cross-linked ones. This also preserved the matrix components and the other factors bound to 
those collagens. These include the proteoglycans, whose glycosaminoglycan chains constitute 
the chemical scaffolds for cytokines and growth factors (8). The resulting biomatrix scaffolds 
consist of a complex of collagens, collagen-bound extracellular matrix components, cytokines, 
and growth factors that act as a supporting framework and provide a composite set of signals 
for cell migration, proliferation, and differentiation (130, 203). Frozen sections of liver biomatrix 
scaffolds have been shown to promote the differentiation of hHpSCs to mature parenchymal 
cells and to maintain this differentiated phenotype for more than 8 weeks (8). The biophysical 
and biochemical properties of these biomatrix scaffolds are tissue-specific and retain 
localization of matrix components in histologically accurate fashion.    
Biomatrix scaffolds retain patency with respect to the vascular channels (8, 201). Indeed, 
ultrasound imaging of the biomatrix scaffolds indicated a matrix architecture far more complex 
than scaffolds that are primarily or solely cross-linked collagens.  The biomatrix scaffolds have  
branching vascular and microvascular channels down to ~150 microns – levels close to those of 
capillaries. There are no other protocols that retain microvascular channels to this extent (201).  
The intact biomatrix scaffolds were shown also to permit hepatic organoid formation, 
with retention of acinar-specific localization of those functions assayed, even when 
recellularized with a hepatoma cell line, Hep3B (201). Efforts are ongoing to use biomatrix 
scaffolds for recellularization with normal fetal liver cell suspensions (Hanson et al. Manuscipt in 
preparation).  
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Initial efforts to exploit the potency of the biomatrix scaffolds for industrial scale culture 
systems made use of pulverized scaffolds that were dispersed onto culture dishes (8). However, 
the plating of the pulverized matrix onto plastic resulted in a loss of some of the biological 
activity due to what is assumed to be a loss of factors that became soluble in the culture media 
because the matrix was pulverized. To overcome this deficit, we elected to mix the powdered 
biomatrix scaffolds with hyaluronans to preserve the biologically active factors, and then to 
embed the hHpSC colonies into the mix. To maximize the ability to readily retrieve the cells, the 
hyaluronans used were not cross-linked into a stable hydrogel. Consequently, a nominal 
amount of hyaluronan is lost with each medium change. Initially, the culture mixture is thick and 
viscous but gradually acquires the consistency of a slightly viscous liquid. This allows for the 
hHpSC colonies to form into organoids when initially cultured in the pLBM-HA system and to be 
carefully removed without further manipulation after 5 days in culture to be utilized in additional 
testing.  
Hyaluronans are ideal as a base material to be mixed with the powdered biomatrix 
scaffolds. They are conserved across species, are a primary component of all stem cell niches, 
and do not cause any inflammatory or immunologic responses (204). They form hydroscopic, 
non-rigid structures with perfect elasticity; are fully equilibrated with all components in the 
medium, but have no sulfate groups and very few sites for binding of signaling molecules. Thus, 
the signaling components will be derived from the powdered scaffold material combined with the 
hyaluronans. The efforts of Glenn Prestwich et al. (U. Utah) have resulted in chemical strategies 
to generate modular units of hyaluronans that can be assembled into cost effective biomaterials 
useful for tissue engineering strategies (204-207). Hyaluronans are an FDA approved product 
that is readily available and are already used in clinical applications such as the repair of 
wounds and the regeneration of organs (43, 208). Combining all of these factors with the ease 
with which this molecule can be modified makes hyaluronan an ideal biomaterial in the 
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fabrication of a culture system that can promote the differentiation of hepatic stem cells to 
mature liver cells.   
The pulverization of the liver biomatrix scaffolds is essential for scalability. The process 
eliminates the gross, macroscopic and microscopic native structure of the scaffold but preserves 
the matrix components in a powder form. As valuable as that native structure is, it is a barrier to 
industrial scalability. By pulverizing the scaffold, it is feasible to provide the matrix components 
in a digitized form, and when in combination with the hyaluronans, a form can be presented in 
3D. A critical step in the method was to optimize the ratio of hyaluronans to biomatrix scaffold 
material to elicit the differentiation effects desired. Secreted protein analysis suggests that the 
metabolic activities of the hHpSC colonies seeded in the pLBM-HA cultures are dependent on 
liver biomatrix concentration. Increases in the secretion rates of factors that indicate hepatic 
functionality (e.g. Albumin) correlated to increases in pulverized liver biomatrix concentration 
with the concentration of 100 mg/ml having the greatest increase. The pulverized liver biomatrix 
could be seen to influence the hHpSCs at concentrations as low as 10 mg/ml. However, 
concentrations above 100 mg/ml seemed to have a detrimental effect on the secretion of these 
factors suggesting that this concentration is the upper limit for healthy hHpSC cultures. When 
hHpSCs were cultured using undiluted pulverized liver biomatrix alone, most cells did not 
survive (data not shown). It is possible that there may be a salt residue left in the biomatrix after 
decellularization that is negatively affecting the hHpSCs and that the pulverization process is 
only magnifying that impact. When lower concentration levels were tested and the secretion 
rates of cultures with pulverized liver biomatrix were compared to cultures with only hyaluronan, 
it is clear that the differentiation potential of the hHpSC colonies is positively affected by 
pulverized liver biomatrix and that certain concentrations can have a promotive effect on the 
hepatic differentiation of the hHpSCs. 
 Analysis of gene expression provides evidence that the survival and growth of these 
hHpSCs in these cultures of pulverized biomatrix and hyaluronan mixtures are concentration 
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dependent; the pulverized biomatrix concentration can be adjusted to levels that promote 
healthy cell culture and differentiation. Common stem cell markers such as CXCR4 and 
EpCAM, along with early hepatocytic genes including CK19 and CK7, were evaluated. EpCAM 
is typically found in cell-cell binding interactions while CXCR4 is a transmembrane cell surface 
receptor. Both are found periportally in the adult liver and are stabilized in cells bound to 
hyaluronans (65, 209). CK19 and CK7 are intermediate filament proteins partly responsible for 
structural integrity in the cytoplasm (73). These markers were found to be at levels that were 
either comparable or lower than the levels found in the hHpSC controls, suggesting that some of 
the cells had maintained some properties of a stem cell phenotype while some had 
differentiated into phenotypes that lack the expression of these genes (i.e. mature hepatocytes).  
The hHB marker, AFP, and the expression of albumin, found in hHBs and in mature 
hepatocytes, were also evaluated. AFP is a secreted protein that binds various factors found in 
serum and is replaced by albumin in more mature hepatocytic cell phenotypes (77). Gene 
expression of both of these markers had a positive correlation with the concentration of 
pulverized biomatrix and the difference between the cultures with pulverized biomatrix and 
without pulverized biomatrix was even more pronounced after 7 days despite an overall 
decrease in gene expression levels. These results provide evidence that these hHpSCs have 
differentiated into cell phenotypes that are similar or even more mature than hHBs and 
committed hepatocytic progenitors.  
Mature hepatocytic markers that were assayed were zone 1 genes, such as glucose-6-
phosphatase (G6PC), and zone 2 genes such as tyrosine amino-transferase (TAT) and 
transferrin. G6PC is the rate-limiting enzyme in hepatic glycogenolysis and gluconeogenesis, 
while TAT is an enzyme that breaks down the tyrosine found in many foods. Both activities are 
found in mature hepatocytes particularly in the midacinar zone (210, 211). Transferrin plays a 
major role in iron uptake, required by all polymerases, and in metabolism in mature hepatocytes 
(212). These mature hepatocytic genes were also expressed in a concentration dependent 
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manner and also had a positive correlation with respect to an increase in pulverized matrix 
concentration. From these results, it is reasonable to conclude that many of the hHpSCs have 
differentiated into cell phenotypes similar to that of mature parenchymal cells. 
In this study, we outline a method that utilizes the pulverized product of a 
decellularization procedure that preserves more of the native matrix components than other 
existing protocols and mixes them with hyaluronan to enable use of the mix for industrial scale 
stabilized cultures of hepatic organoids. We show that the composition of the microenvironment 
surrounding human hHpSCs in culture can drive differentiation. More specifically, these 
experiments examine the correlation between modifying the biological properties of a 
microenvironment and their growth and differentiation by subjecting hHpSCs to various 
concentrations of matrix components that comprise the pulverized product of a decellularized 
liver biomatrix scaffold. The pulverized matrix and hyaluronan used in our culture system are 
cross species compatible (213, 214) and biodegradable (204, 215) and thus have the potential 
to be cost effective and a safe option for in vivo cell-based therapies. The pLBM-HA mixture can 
act as the initial support structure for the transplanted cells by either facilitating or maintaining 
their differentiation in hopes that these cells will eventually be able to secrete their own 
extracellular matrix to gradually replace the originally supplemented microenvironment.  
Our method also provides an ex vivo model for the study of stem cell functions in a 3D 
culture microenvironment that is more representative of the environment found in the native liver 
and allows for the accelerated growth and differentiation of these stem cells to phenotypes 
similar to those of mature hepatocytes. Since this pulverization product is industrially scalable, 
this method overcomes any size constraints of the source of the decellularized tissue and can 
conceivably be used to mass-produce culture systems which have implications in numerous 
industrial applications. 
  
 
Figures and Tables 
Figure 20: Schematics of the Decellularization of Liver and Preparation of Grinding Vials 
 
 
 
91 
  
Figure 21: Collagen Analysis and Growth Factor Array of Decellularized Tissue compared to Fresh Liver Tissue. All data reported as 
mean ± 1 standard deviation 
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Figure 22: Schematics of the Pulverization Process and Preparation of LBM-HA Culture Materials 
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Figure 23: Schematics of the Preparation of Pulverized Liver Biomatrix and Hyaluronan Cultures 
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Figure 24: Phase contrast imaging of hHpSC colonies in pLBM-HA cultures. Day 1 (A) and Day 5 (B) of culture in 0 mg/ml of 
pulverized liver biomatrix and 20 mg/ml of hyaluronan. Day 1 (C) and Day 5 (D) of culture in 50 mg/ml of pulverized liver biomatrix 
and 20 mg/ml of hyaluronan. Day 1 (E) and Day 5 (F) of culture in 100 mg/ml of pulverized liver biomatrix and 20 mg/ml of 
hyaluronan. Some colonies could be seen to have formed attachments to the culture surface after 5 days (blue arrows). 
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Figure 25: Functional assays of hepatic functions over time to compare hHpSCs when cultured at various concentrations of 
pulverized biomatrix hyaluronan mixed with hyaluronans. AFP and Albumin secretion are reported as fold change normalized to initial 
target levels 24h after seeding. (A) Change in AFP secretion measured over time. (B) Change in Albumin secretion measured over 
time. Significance levels for secretion rates of hepatic factors (p-value: * < 0.05, ** < 0.01, *** < 0.001) are reported with respect to 
secretion rates 24h after seeding for each pulverized biomatrix concentration (two-tailed Student’s t-test). All data reported as mean 
± 1 standard error. 
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Figure 26: Gene Expression levels for differentiation markers in hHpSCs cultured in Human Differentiation Medium for Liver with 
hyaluronan and various concentrations of pulverized biomatrix after 5 days by qRT-PCR. Target mRNA expression levels are 
normalized to GAPDH expression and fold changes are normalized to initial target mRNA expression levels in hHpSCs . Significance 
levels for secretion rates of hepatic factors (p-value: * < 0.05, ** < 0.01, *** < 0.001) are reported with respect to expression levels of 
hHpSCs isolated the same day the cultures were started (two-tailed Student’s t-test). All data reported as mean ± 1 standard 
deviation. 
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Figure 27: Gene Expression levels for differentiation markers in hHpSCs cultured in Human Differentiation Medium for Liver with 
hyaluronan and various concentrations of pulverized biomatrix after 7 days by qRT-PCR. Target mRNA expression levels are 
normalized to GAPDH expression and fold changes are normalized to initial target mRNA expression levels in hHpSCs. Significance 
levels for secretion rates of hepatic factors (p-value: * < 0.05, ** < 0.01, *** < 0.001) are reported with respect to expression levels of 
hHpSCs isolated the same day the cultures were started (two-tailed Student’s t-test). Target mRNA expression levels of samples at 
the concentration of 100 mg/ml are also compared to the samples at 0 mg/ml for significance (blue). All data reported as mean ± 1 
standard deviation. 
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Figure 28: Gene Expression levels for the mature hepatocyte marker transferrin in hHpSCs cultured in Human Differentiation 
Medium for Liver with hyaluronan and various concentrations of pulverized biomatrix after 5 and 7 days by qRT-PCR. Target mRNA 
expression levels are normalized to GAPDH expression and fold changes are normalized to initial target mRNA expression levels in 
hHpSCs. Significance levels for secretion rates of hepatic factors (p-value: * < 0.05, ** < 0.01, *** < 0.001) are reported with respect 
to expression levels of hHpSCs isolated the same day the cultures were started (two-tailed Student’s t-test). All data reported as 
mean ± 1 standard deviation. 
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Supplemental Figures and Tables 
Table 4: Primer sequences used in gene expression assays for hHpSC differentiation 
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Figure 29: Comparison of differentiation marker gene expression levels between mature hepatocytes and hHpSCs cultured in 
Human Differentiation Medium for Liver with hyaluronan and various concentrations of pulverized biomatrix after 5 days by qRT-
PCR. Target mRNA expression levels are normalized to GAPDH expression and fold changes are normalized to initial target mRNA 
expression levels in hHpSCs. All data reported as mean ± 1 standard deviation. 
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Figure 30: Comparison of differentiation marker gene expression levels between mature hepatocytes and hHpSCs cultured in 
Human Differentiation Medium for Liver with hyaluronan and various concentrations of pulverized biomatrix after 7 days by qRT-
PCR. Target mRNA expression levels are normalized to GAPDH expression and fold changes are normalized to initial target mRNA 
expression levels in hHpSCs. All data reported as mean ± 1 standard deviation. 
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Figure 31: Gene Expression levels for stem cell markers in hHpSCs cultured in Human Differentiation Medium for Liver with 
hyaluronan and various concentrations of pulverized biomatrix after 5 days by qRT-PCR. Target mRNA expression levels are 
normalized to GAPDH expression and fold changes are normalized to initial target mRNA expression levels in hHpSCs. All data 
reported as mean ± 1 standard deviation. 
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Figure 32: Functional assays of hepatic functions over time to compare hHpSCs cultured in Kubota’s Medium to hHpSCs cultured in 
Human Differentiation Medium for Liver. Cultures consisted of hyaluronan and various concentrations of pulverized biomatrix. AFP 
and Albumin secretion are reported as fold change normalized to initial target levels 24h after seeding. (A) Change in AFP secretion 
measured over time. (B) Change in Albumin secretion measured over time. All data reported as mean ± standard error. 
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Figure 33: Gene Expression levels for differentiation markers to compare hHpSCs cultured in Kubota’s Medium to hHpSCs cultured 
in Human Differentiation Medium for Liver with hyaluronan and various concentrations of pulverized biomatrix after 5 days by qRT-
PCR. Target mRNA expression levels are normalized to GAPDH expression and fold changes are normalized to initial target mRNA 
expression levels in hHpSCs. All data reported as mean ± 1 standard deviation. 
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CHAPTER VI 
 
Conclusions 
 
Rationale Behind ex vivo Model Development 
Liver regenerative medicine research has become a multidisciplinary effort with 
contributions from diverse fields. A common focus of these studies has been on either 
regenerating or fully replacing the tissue of the liver with the end goal of restoring some degree 
of functionality. There has also been a focus on using these technologies as a model system for 
liver disease research and studies on drug response and toxicity. Many industry standard 
protocols that are currently being used in the study of various drug and chemical hepato-
toxicities utilize hepatocytes cultured either on plastic or in suspension. Even though these 
primary human hepatocytes most accurately model liver disease and the hepatotoxicity of 
drugs, many problems are associated with these models including the limited availability of 
these cells, variability between donors, and inability of current culture systems to maintain 
hepatic phenotypes or even sustain viable cultures.  
It is evident that there is a need for a sustainable source of mature hepatocytes and for 
improved in vitro three-dimensional (3D) culture systems that integrate the external cues 
needed for healthy hepatic cultures. Some of these cues include the gradients of the various 
extracellular matrix (ECM) components, gradients in the soluble signals in the plasma, and the 
mechanical properties found in the liver. Systems that give recognition to these variables have 
already been found to be integral to the differentiation of stem cells to functional hepatocytes.  
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In vitro models can be more easily manipulated and controlled while allowing scalability.  
They can provide the materials for high-throughput testing of various combinations of 
experimental parameters. The integration of increasingly complex combinations of cell types, 
culture techniques that mimic the native structural and mechanical properties of the liver, and 
extracellular matrix scaffolds with the native matrix components preserved has allowed for the 
recapitulation of the native liver environment to varying degrees. Application of these culture 
systems to industrial applications are especially attractive due to their ability to provide a 
representative environment that incorporates various native properties of the liver that can be 
scalable – such a method would enable cost-effective drug and toxicology studies.  
  
Ex Vivo Maintenance Concerns including 2D vs 3D and Culture Media 
The interactions between cells and their surrounding environment are integral to their 
viability and functionality. Recent developments in cell culture have transitioned from monolayer 
(2D) to 3D cultures. Studies in the past that have utilized 2D cultures had cells with severely 
muted tissue-specific functions (usually less than 1% of the levels of functions in vivo) and with 
regulation of genes found to be entirely posttranscriptional mainly due to properties that affect 
the half-life, translation efficiency, and protein stability (13). Transcriptional regulation of tissue-
specific genes has been shown dependent on the presence of specific soluble signals (growth 
factors, cytokines, hormones), certain extracellular matrix components (especially the 
proteoglycans), and the ability of the cells to change shape in order for the chromatin to undergo 
requisite topological changes to bring specific regulatory elements into registration (29, 82, 83).  
Three-dimensional systems have become the focus of studies on hepatic functions (or 
rather the tissue-specific functions of all differentiated cells) as these cultures promote the self-
assembly of tissues and achieve cell differentiation at levels previously not seen in traditional 
monolayer culture systems. Recent studies have shown that there are complex and dynamic 
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interactions between the configuration of the ECM and the various intracellular activities that 
regulate hepatocyte morphology and hepatic function.  
Classical cell culture since the 1940s has comprised use of glass or plastic substrata 
cultured with basal media supplemented with some type of serum. Eventually it was realized 
that serum is not a logical biological fluid to use in cultures as no cell in the body is in contact 
with serum except in a wound – conditions that drive cells towards a fibrotic or cirrhotic 
response (i.e. scar tissue formation). Due to the pioneering work of Gordon Sato in the 1970s 
and early 1980s, there was a transition to utilizing serum-free, hormonally defined media (HDM) 
with the constituents defined with respect to the cell type, the maturational lineage stage of the 
cell, and the physiological functions to be achieved (216). The use of HDM enabled the 
posttranscriptional regulation of tissue-specific functions in cells to be stabilized. However, the 
HDM did not lead to restoration of transcriptional controls of tissue-specific genes (13).  It was 
learned subsequently that matrix components, particularly proteoglycans, in combination with 
the HDM, were required to restore mRNA synthesis of these genes (83). 
 
Importance of Extracellular Matrix and Maturational Gradients 
Recent studies have also shown the importance in the composition of the ECM in the 
culture of hepatic cell types. The ECM has been described as the scaffolding of all organs with 
insoluble chemical signals and cues that allow for the organization of tissues and the cells within 
those tissues. The same groups of molecules can be found in different tissue types, and it is 
their respective ratios, concentrations, and their array of interactions with the cells that affect 
their differentiation and consequently their functions.  
Culture methods have been developed making use of dishes coated with attachment 
proteins or collagens, of embedding cells into hydrogels (e.g. collagen-based gels, Matrigel, 
alginate, and even PEG-based gels). Although far more functional than cells on culture plastic, 
these cells miss the dynamic interactions between multiple cell types that provided the 
  109
necessary cell-cell interactions needed for proper hepatocyte functions. Because of the diversity 
of functions that can be found in the multitude of cells that comprise a tissue, the composition 
and structure of the ECM varies based on the function the cells in the area serve.  
The structure of the ECM of various tissue types is organized into both microstructural 
and macrostructural units that each provide a unique set of signals to the cells within. 
Specifically in the liver, there is a microstructural organization of the various extracellular 
components that provide the zonation of signals and cues to form a maturational gradient 
beginning with the most immature cells, such as the stem cells located around the portal triad, 
to the fully mature cells around the central vein within each acinus. Such a gradient exists in all 
tissues and organs. The matrix chemistry in the stem cell niches transitions to matrix 
chemistries distinct for each mature cell type in the tissue or organ. That chemistry derives from 
factors from the epithelial cells, the mesenchymal cells, and other cell types (e.g. neuronal 
cells), and constitutes the paracrine signals among these various cell types in the community 
forming the tissue or organ. The epithelial cells, and in parallel, their partner mesenchymal cells 
progress through the maturational lineage stages coordinated with one another via the 
paracrine signaling.  
Recent studies that utilize purified ECM substrata to culture cells overlook the fact that 
the ECM is incredibly complex with many factors and components yet to be identified. This 
dynamic mixture of matrix components and factors cannot be replaced simply by individual 
matrix components or a mixture of these purified components.  
 
Rationale Behind Decellularization Processes and Strategy Comparison 
All of these findings have driven the development of decellularized organs to establish 
matrix extracts for use with in vitro models. These matrix extracts provide a more 
comprehensive representation of the complexity of the native ECM. The rationale behind all of 
the protocols is to eliminate nucleic acids, cytoskeletal proteins, and various other cellular 
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components but to leave behind as much of the original matrix as possible. All other protocols 
make use of freeze-thawing (which damages vascular channels), while some use enzymes 
(which damages many different matrix components). Others have delipidation steps often with 
harsh detergents, such as sodium dodecyl sulfate (SDS), that bind permanently to the matrix 
and then use low ionic strength buffers (some even use distilled water) that washes away all but 
the cross-linked collagens and anything that is not bound tightly to these cross-linked collagens.  
By contrast, our protocol focuses on the collagen chemistry as established by collagen 
chemists in the 1970s and makes use of a strategy of extracting with buffers that preserve all of 
the known collagens of the tissue including both the cross-linked and non-cross-linked and even 
the nascent (newly synthesized) collagens. Thus, the protocol used collagen chemistry as a 
“hook” to retain all of the collagens and anything bound to those collagens. The net result is that 
the scaffolds generated by our strategies are far more complex and contain most (if not all) of 
the native attachment proteins, proteoglycans, and other components. Also retained are 
physiological levels of all known growth factors, hormones and cytokines that are matrix bound. 
The extract has been shown to be potent in the maintenance of cells ex vivo.  
 
Non-invasive Ultrasound Techniques for Evaluation of Matrix Substrata 
Recent developments in ultrasound techniques have enabled a more thorough way to 
characterize these biomatrix scaffolds by non-invasive methods. Ultrasound technologies are 
currently used in a variety of therapeutic and imaging applications. A new application that has 
recently been realized is the utilization of this technology non-invasively to visualize the 
structure and to characterize the material properties of these scaffolds. This technology will 
provide quantitative tools to monitor the functionality of the scaffolds in real-time. Feedback will 
be available immediately for the optimization of various parameters during scaffold fabrication 
studies and will obviate the use of destructive methods in scaffold analysis. Specifically in our 
studies, the use of microbubbles as a contrast agent in conjunction with two distinct contrast-
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enhanced ultrasound methods helped us analyze the structure of the scaffolds. We were also 
able to visualize and quantify the vascular channels at levels close to the capillary levels while 
mapping perfusion rates throughout the scaffold after decellularization. Knowledge of the 
patency and flow rates of various areas within the scaffold allow for the selection of patent 
scaffolds and the optimization of recellularization efforts. Our technique has the potential to be a 
cost-effective method to characterize these scaffolds at a higher depth and resolution than other 
technologies such as optical imaging. Although the matrix scaffolds are the logical 3D substrata 
for cells, they are not readily scalable for industrial scale experimental protocols and 
applications. 
  
Organoid Cultures 
Organoid Cultures typically incorporate multiple cell types that have the potential to 
aggregate into small functional units making use of the cell types normally organized together 
within the 3D microenvironment of the tissue or organ. These are now increasingly popular, 
since they can be established rapidly and easily, and the cells remain viable and functional for 
weeks to months (especially when cultured in serum-free HDM). They show the importance of 
the variables noted above including the need for a) serum-free conditions; b) specific mixes of 
purified hormones, nutrients, and cytokines; c) three dimensionality; d) mixes of the key cell 
types to establish epithelial-mesenchymal relationships (which have long been known as 
important).   
Disrupting the native cell-cell interactions results in a loss of differentiated functions and 
minimizes their ability to metabolize drugs or to behave in physiologically specific ways. The 
newest variable is that these relationships are lineage dependent with specific lineage stages of 
epithelial cells partnered with particular stages of mesenchymal cells with the paracrine 
signaling being distinct at each lineage stage. 
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The recurring themes are that the co-culture of hepatocytes or hepatic-specific iPSCs 
with non-parenchymal cell types will always yield hepatocytes with higher levels of functionality 
than when hepatocytes are cultured alone. These organoid culture methods yield hepatocytes 
at higher functional levels dependent on how the organoids are assembled and with the 
differences in the level of functionality increasing as time progresses through the experiment.  
Even though the assay techniques utilized to evaluate the functionality of the 
hepatocytes in these studies were incredibly diverse, a commonly used assay that roughly 
allows comparison is the secretion of albumin. However, even for albumin secretion, many of 
the units of measurement cannot be reconciled and thus limit comparability except in a few 
cases. The most significant result could be seen when comparing our method with one used by 
Huch et al. (6). This was the only group to compare their albumin secretion to that of mature 
hepatocytes. The LGR5+ liver stem cells in their study were able to achieve ~5% of the albumin 
secretion of mature hepatocytes, while our hHpSCs isolated from fetal livers were able to 
achieve ~20%. This increase can most likely be attributed to the potency of our matrix extract 
that we added to the organoid cultures. Presented to our hHpSCs in a pulverized form, this 
biomatrix scaffold powder still maintained the original factors from the decellularized scaffold 
and conceivably stabilized the culture and accelerated the differentiation of these stem cells to 
functional cell types similar to mature hepatocytes.  
  
Current Status of in vitro Model Development 
The development of a reproducible and sustainable in vitro culture of fully differentiated 
hepatocytes with complete functionality for extended periods of time has been the goal of many 
studies. Demand for an in vitro model system that can be used to accurately understand the 
relationship between the exposure to a certain drug or compound and the respective cellular 
and metabolic responses is only increasing as the need for novel and improved therapies 
becomes greater. Much progress has been made in the understanding of cell-cell interactions, 
  113
the importance of the composition and configuration of the ECM, the relationship between 
gradients of these matrix molecules that form zonal microenvironments and the maturational 
lineages of the various mesenchymal and epithelial cell types within the liver. This level of 
understanding is completely necessary in the development of hepatic culture systems that are 
able to mimic the drug toxicities found in vivo by accurately reproducing the attempts of these 
cells to metabolize and adapt to these substances.  
 
Current Major Challenges in the Development of in vitro Models 
Many challenges currently exist towards achieving this goal. Further studies need to be 
performed to better understand various aspects of hepatocyte activity including the pathways 
and systems that are associated in the uptake, metabolism, and excretion of these toxins. Also, 
the interactions between cells specifically pertaining to how they adapt to the exposure of toxins 
needs to be better understood. Finally, very few in vitro systems have been developed that fully 
recapitulate the complex 3D architecture of the liver specifically relating to the relationship 
between the hepatic sinusoids and the bile ducts. Much development is still needed to develop 
a system that fully mimics the architecture found in the native liver.  
 
Future Directions of Our Studies 
Further studies will need to be performed to more thoroughly assay the level of 
functionality achieved with our method. Questions that need to be addressed include whether 
addition of select purified matrix components (e.g. type IV collagen, laminin) to the hydrogels, 
along with the biomatrix powder, will confer even greater functions. Also needed is empirically to 
test the scalability of the system. Studies need to be performed to determine how large the 
volumes of the hydrogels can be and still retain the ability of nutrient and soluble signal access. 
The future of this approach to attaining better model systems and improving cell-based 
therapies is incredibly promising. 
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Future Applications of in vitro Models 
Developments in any of these areas noted above will help in progressing towards the 
goal of creating an in vitro system that can be used in both therapeutic and industrial 
applications. The use of these systems in therapeutic applications will require the incorporation 
of multiple human cell types into these systems making the customization and personalization of 
these treatments to each patient possible. Specifically in the industry, the use of these systems 
in preclinical studies can make immediate and significant impacts by providing an in vitro model 
of the liver that can be carefully controlled and scaled. These models can be used to accurately 
model the metabolism of drugs and their toxicities to identify new treatments. These systems 
can also be used to better understand the paracrine signaling between cells in various 
maturational lineage stages and this knowledge would allow better control over the functionality 
of the cells. Additionally, these systems can be used to eliminate compounds early on in the 
drug development process to reduce time and costs and better prevent patients from being 
exposed to improperly tested and dangerous compounds in clinical trials. Finally, they can be 
used in research to avoid many concerns involved with in vivo testing in regards to scientific and 
ethical dilemmas. 
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